Smoking Cessation

Synonym
Smoking Cessation

Excerpt	Reference
"Weight gain after smoking cessation is often cited by women smokers as a primary reason for not attempting to quit smoking or for relapsing after a cessation attempt."	( Allen, S; Hatsukami, D; Hellerstedt, W; Jeffery, RW; Lando, H; McBride, CM; Pirie, PL, 1992)
"Failure in smoking cessation is linked with behavioural factors and with nicotine dependence, due to the psychoactive effects of the drug, mainly on locus ceruleus and on mesolimbic dopaminergic system."	( Prignot, J, 1995)
"The stages of smoking cessation are precontemplation, contemplation, action, and maintenance; interventions are selected on the basis of the stage the smoker is in."	( Haxby, DG, 1995)
"Smoking cessation is a complex process and not a simple event."	( Petty, TL, 1993)
"Smoking cessation is a very important intervention in reducing cardiovascular risk in hypertensive patients."	( Bindra, RS; Kochar, MS, 1996)
"Smoking cessation is associated with significant improvements in salivary bicarbonate secretion."	( Kershaw, J; Riley, SA; Smith, LF; Trudgill, NJ, 1998)
"Although smoking cessation is not simple, in the years spanning 1993 to September 1997, 1720 articles were published under the key words "smoking cessation," reflecting the difficulty of this endeavor and lack of a satisfying answer to this health problem."	( Berkowitz, HD; Kerstein, MD; Terry, ML, 1998)
"Smoking cessation is an arduous process because nicotine withdrawal syndrome, which occurs following sudden interruption of nicotine use in long-term smokers, frequently prevents them from giving up the habit."	( Chen, YM; Chiang, SJ; Hsieh, WC; Lu, CC; Perng, RP, 1998)
"Therefore, smoking cessation is the most important therapeutic approach."	( Perruchoud, AP; Solèr, M; Ullmer, E, 1999)
"Smoking cessation is associated with weight gain and improvement in insulin resistance."	( Assali, AR; Beigel, Y; Fainaru, M; Schreibman, R; Shafer, Z, 1999)
"Relapses in smoking cessation are due to nicotine craving and the attempt to alleviate symptoms of nicotine withdrawal."	( Nichols, MR, 1999)
"Smoking cessation is a key intervention for prevention of several lung diseases."	( Mikkelsen, KL; Tønnesen, P, 2000)
"Effective smoking cessation is relevant at all stages of the disease."	( Calverley, PM, 2001)
"Although smoking cessation is seen as the single most important way of preventing a further deterioration of the lung function at all stages of chronic obstructive pulmonary disease (COPD), little research has been conducted amongst COPD patients."	( Huibers, MJ; van Schayck, CP; Wagena, EJ, 2001)
"Smoking cessation is also associated with the expression of an abstinence syndrome that can, largely, be attributed to nicotine withdrawal and is also likely to contribute to the maintenance of the habit."	( Balfour, DJ, 2002)
"Smoking cessation is difficult due to nicotine addiction and withdrawal symptoms."	( Karnath, B, 2002)
"Smoking cessation is an important aspect of the treatment of many diseases."	( Campbell, IA; Cannings, R; Edwards, S; Hand, S, 2002)
"Successful smoking cessation is a major public health goal."	( Gilpin, EA; Pierce, JP, 2002)
"Smoking cessation is the only strategy that reduces this decline in lung function, and although bupropion is the most effective aid to quitting, more effective treatments of nicotine addiction are needed."	( Barnes, PJ, 2003)
"In smokers, smoking cessation is associated with improved 5-year outcome."	( Abdenbi, K, 2002)
"Smoking cessation is the most effective way to reduce the risk of developing chronic obstructive pulmonary disease (COPD) or to reduce its progression."	( van Schayck, CP; Wagena, EJ; Wouters, EF; Zeegers, MP, 2003)
"Cigarette smoking cessation is followed by a marked increase in plasma antioxidant concentrations and substantially improves plasma resistance towards oxidative challenge."	( Mecocci, P; Polidori, MC; Sies, H; Stahl, W, 2003)
"Weight gain after smoking cessation is increased in those with higher baseline levels of leukocytes and fibrinogen."	( Chambless, LE; Duncan, BB; Folsom, AR; Heiss, G; Schmidt, MI, 2003)
"Smoking cessation is the single most effective- and cost-effective-way to reduce the risk of developing COPD and stop its progression."	( Kawane, H, 2003)
"Smoking cessation is a basic standing point for management of COPD."	( Toyoshima, H; Yoshida, M, 2003)
"Smoking cessation is associated with substantial health benefits."	( Fernández Pinilla, MC; Fernández-Cruz, A; Filozof, C, 2004)
"Smoking cessation is associated with a 65% reduction in the risk of a relapse as compared with continued smokers, a similar magnitude to that obtained with immunosuppressive therapy."	( Cosnes, J; Johnson, GJ; Mansfield, JC, 2005)
"Smoking cessation is an important factor in the primary and secondary prevention of cardiac events."	( Eisenberg, MJ; Ludvig, J; Miner, B, 2005)
"Smoking cessation is an important part of every primary care physician's work."	( Barenboim, E; Goldstein, L; Grossman, A; Landau, DA, 2005)
"Obstructions to smoking cessation are often numerous and complex."	( Errard-Lalande, G, 2005)
"Smoking cessation is the only known causative treatment option."	( Bitter-Suermann, S; Kanniess, F; Magnussen, H; Watz, H, 2006)
"Smoking cessation is associated with transient increases in body weight."	( Joe, KH; Kim, DJ; Kim, W; Lee, DH; Lee, H; Park, J; Sung, KW, 2006)
"Smoking cessation is the only intervention that has proved effective."	( Montuschi, P, 2006)
"As smoking cessation is important to reduce risk of cardiovascular morbidity, especially in diabetes, use of effective drugs indicated for smoking cessation is rational."	( Kristensen, PL; Pedersen-Bjergaard, U; Thorsteinsson, B, 2008)
"Levels of smoking cessation care are less than optimal in hospitals, and the levels of some important care practices are particularly low."	( Campbell, E; Freund, M; Knight, J; McElduff, P; Paul, C; Sakrouge, R; Walsh, RA; Wiggers, J, 2008)
"Smoking cessation is the only available intervention proven to halt progression of chronic obstructive pulmonary disease (COPD)."	( Chitkara, R; Krishna, G; Mohanasundaram, UM, 2008)
"smoking cessation is unique to individual women; as such, appropriate support and advice should be tailored accordingly."	( Ashwin, CA; Watts, K, 2010)
"Smoking cessation is without question the best approach to minimizing smoking-induced ill health and disease, but success rates among those who attempt to quit are dismal."	( Bloomer, RJ; Fisher-Wellman, K, 2009)
"Smoking cessation is associated with health benefits for people of all ages."	( Cryan, JF; Flynn, RA; Glynn, DA; Kennedy, MP; Kent, P, 2009)
"Smoking cessation is associated with substantial health benefits."	( Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL, 2010)
"Smoking cessation is the most effective and least expensive single means of lowering the risk of developing COPD and of arresting its progression."	( Andreas, S; Hering, T; Mühlig, S; Nowak, D; Raupach, T; Worth, H, 2009)
"Smoking cessation is usually mentioned last in the chain of established measures to improve Tobacco Control."	( Bolliger, CT, 2009)
"Smoking cessation is a key component of secondary cardiovascular disease prevention."	( Arteaga, C; Benowitz, NL; Garza, D; Pipe, AL; Rigotti, NA; Tonstad, S, 2010)
"Smoking cessation is the most effective action to reduce mortality in patients with chronic obstructive pulmonary disease (COPD) and coronary heart disease."	( Quist-Paulsen, P, 2008)
"Smoking cessation is difficult due to nicotine addiction and withdrawal symptoms."	( Bhat, A; Crain, D, 2010)
"Smoking cessation is a hard process."	( Meyer, A; Stolz, D, 2010)
"Counselling smoking cessation is clearly shown to be both efficient and cost-effective in terms of years of live saved."	( Zeller, A, 2010)
"Promoting smoking cessation is among the key medical interventions aimed at reducing worldwide morbidity and mortality in this century."	( Raupach, T; van Schayck, CP, 2011)
"The goals of smoking cessation are both to reduce health risks and to improve quality of life."	( Domínguez-Delgado, CL; Escobar-Chávez, JJ; Rodríguez-Cruz, IM, 2011)
"Smoking cessation is a process that unfolds over time and is characterized by intermittent lapses."	( Kirchner, TR; Shiffman, S; Wileyto, EP, 2012)
"Smoking cessation is associated with significant improvements in quality of life, mortality, life expectancy, and postsurgical complication rates."	( de Hoyos, A; DeCamp, MM; Southard, C, 2012)
"Smoking cessation is widely recommended for secondary stroke prevention."	( Bak, S; Brunner Frandsen, N; Henriksen, RM; Hyldahl, TK; Sørensen, M, 2012)
"Smoking cessation is beneficial for our health at any point in life, both in healthy people and in people already suffering from a smoking-related disease."	( Alvarez-Ossorio, C; Buades, A; Esteva, M; García, E; Girauta, H; Gorreto, L; Medina-Bombardó, D; Pastor, A; Ramos, M; Ripoll, J; Torres, E; Uréndez, A, 2012)
"Smoking cessation is an important aim in public health worldwide as tobacco smoking causes many preventable deaths."	( Gallagher, T; Haseler, CA; Rucktooa, P; Sixma, TK; Smit, AB; van Elk, R, 2012)
"Smoking cessation is typically verified biochemically by expired-air carbon monoxide (CO) levels below 9 ppm (i."	( Jao, NC; Karelitz, JL; Perkins, KA, 2013)
"Smoking cessation is not a single event but a process, and relapse is an ordinary component of this process."	( Bruno, CM; Caponnetto, P; Keller, E; Polosa, R, 2013)
"The data about smoking cessation are limited; there has not yet been a study primarily focused on changes in steroids levels."	( Dušková, M; Hill, M; Hruškovičová, H; Králíková, E; Pospíšilová, H; Rácz, B; Simůnková, K; Stárka, L; Vondra, K, 2013)
"Smoking cessation is possible for individuals with schizophrenia but the relapse rate is high."	( Bernard, PP; Carayol, MS; Dandonneau, L; Esseul, EC; Ninot, GJ; Raymond, L; Xambo, JJ, 2013)
"The mainstay in smoking cessation is counselling in combination with varenicline, nicotine replacement therapy (NRT) or bupropion SR."	( Tønnesen, P, 2013)
"Smoking cessation is the most effective treatment option in all COPD stages."	( Jenkins, C; Leuppi, J; Osthoff, M, 2013)
"Smoking cessation is a key component of primary and secondary CVD prevention strategies, but tobacco use often receives less attention from cardiologists than other risk factors, despite the availability of proven treatments that improve smoking cessation rates."	( Clair, C; Rigotti, NA, 2013)
"Smoking cessation is associated with transient metabolic changes including increased β-cell secretion in response to glucose and fasting insulin resistance."	( Bech, P; Bieglmayer, C; Brath, H; Dickson, SL; Korbonits, M; Pacini, G; Peric, S; Prager, R; Stadler, M; Storka, A; Tomann, L; Wolzt, M, 2014)
"Smoking cessation is typically followed by withdrawal symptoms and a strong desire to smoke, both of which are likely to contribute to relapse."	( Cramp, A; De Jesus, S; Faulkner, G; Fitzgeorge, L; Harper, T; Mottola, MF; Prapavessis, H; Selby, P; Ussher, M, 2014)
"Smoking cessation is the only intervention in the management of COPD."	( Duan, MC; Huang, Y; Tang, HJ; Zhong, XN, 2013)
"Smoking cessation is followed by increases in bilirubin concentration that have been associated with lower risk of lung cancer and cardiovascular disease."	( Jatlow, PI; Mayne, ST; O'Malley, SS; Wu, R, 2014)
"Smoking cessation is associated with weight gain in most cases."	( Bize, R; Clair, C; Cornuz, J; Gonseth, S; Locatelli, I; Nusslé, S; Pralong, F, 2014)
"Smoking cessation is associated with weight gain mainly through accumulating extra fat, but is also associated with increased muscle mass, muscle strength and bone density."	( Aizenbud, D; Karkabi, K; Keidar, Z; Reznick, AZ; Rom, O, 2015)
"Readiness for smoking cessation is an important predictor of quit attempts and cessation success."	( De Backer, G; De Bacquer, D; Empana, JP; Fras, Z; Heidrich, J; Jennings, C; Keil, U; Kotseva, K; Périer, MC; Prugger, C; Reiner, Ž; Wellmann, J; Wood, D, 2015)
"The percentage of smoking cessation is better in SSCP, although a high smoking cessation rate was obtained in PCP (active search)."	( Antón-García, F; Correcher-Salvador, E; Pruteanu, DF, 2016)
"Importantly, smoking cessation is associated with a decreased risk of subsequent deterioration."	( Obert, J; Tazi, A, 2015)
"Smoking cessation is the most effective strategy for slowing down the progression of chronic obstructive pulmonary disease (COPD) and reducing mortality in the approximately 50% of patients with diagnosed COPD who continue to smoke."	( Tashkin, DP, 2015)
"Smoking cessation is important for the prevention and therapy of PAD, and to this end, counseling by physicians and nicotine replacement therapy are useful and strongly recommended for patients with PAD."	( Hirooka, S; Orita, H; Sotoda, Y; Wakabayashi, I, 2015)
"Weight gain after smoking cessation is a barrier to quitting as well as a negative consequence to health."	( Floden, L; Leischow, SJ; Muramoto, ML; Taren, DL, 2016)
"Smoking cessation is a challenging task with a high risk of relapse."	( Aumann, I; Hagemann, N; Treskova, M; von der Schulenburg, JM, 2016)
"Smoking cessation is the most effective intervention to prevent the annual decline in lung function in patients with chronic obstructive pulmonary disease."	( Uruma, R, 2016)
"Smoking and smoking cessation are both psychological and physiological traits."	( Han, M; Jia, C; Jiang, F; Li, H; Li, S; Pan, L; Wang, Q; Yang, X; Zhang, N, 2016)
"Smoking cessation is the most important treatment for smokers with chronic obstructive pulmonary disease (COPD), but little is known about the effectiveness of different smoking cessation interventions for this particular group of smokers."	( Kotz, D; van der Meer, RM; van Eerd, EA; van Schayck, OC, 2016)
"Although smoking cessation is currently the only guaranteed way to reduce the harm caused by tobacco smoking, a reasonable secondary tobacco control approach may be to try and reduce the harm from continued tobacco use amongst smokers unable or unwilling to quit."	( Begh, R; Fanshawe, TR; Farley, A; Hartmann-Boyce, J; Lancaster, T; Lindson-Hawley, N, 2016)
"Life-long smoking cessation is a critical public health objective, but it is difficult for numerous people."	( Chen, WC; Ho, LI; Ko, HK; Pan, SW; Shie, HG; Yu, WK, 2017)
"Smoking cessation is the most effective treatment in patients with emphysema and lung inflammation."	( Hashidume, N; Kanaoka, Y; Kataoka, Y; Koga, M; Tashiro, T; Yamauchi, A, 2018)
"Incentives for smoking cessation are a response to the responsibility to protect the unborn child."	( Been, JV; Breunis, LJ; de Beaufort, ID; de Jong-Potjer, L; de Kroon, M; Ismaili M'hamdi, H; Steegers, EA, 2020)
"Medications for smoking cessation are currently only effective in helping a minority of smokers quit."	( Hendershot, CS; Le Foll, B; Pipe, A; Reid, RD; Samokhvalov, AV; Selby, P; Thorpe, KE; Tyndale, RF; Zawertailo, L, 2020)
"As cigarette smoking cessation is the best-known environmental factor with beneficial effect in Crohn's disease (CD), more exposome factors are likely involved."	( Alizadeh, BZ; Dijkstra, G; Festen, EAM; Geertsema, P; Rijkmans, HC; van der Sloot, KWJ; van Dullemen, HM; Visschedijk, MC; Voskuil, MD; Weersma, RK, 2021)
"Smoking cessation is important in patients with tuberculosis because it can reduce the high rates of treatment failure and mortality."	( Barua, D; Boeckmann, M; Dogar, O; Elsey, H; Fatima, R; Gabe, R; Huque, R; Keding, A; Khan, A; Kotz, D; Kralikova, E; Li, J; Mansoor, S; Marshall, AM; Parrott, S; Readshaw, A; Sheikh, A; Siddiqi, K; Zahid, R, 2020)
"Smoking cessation is beneficial in asthmatic smokers and associated with (1) a reduction of asthma symptoms, acute exacerbations, bronchial hyperresponsiveness, and bronchial inflammation, (2) decreased use of rescue medications and in doses of inhaled corticosteroids, (3) improved asthma control, quality of life, and lung function."	( Jaafari, N; Peiffer, G; Perriot, J; Underner, M, 2021)
"Smoking cessation is one of the most powerful health promotion tools in the Western world."	( Drazetic, A; Mache, S; Markstein, A; Pankow, W; Rohde, M; Vitzthum, K, 2021)
"Smoking cessation is a difficult task especially in the elderly; therefore, physicians should encourage older patients to quit with every patient-physician encounter by offering counseling and replacement therapy."	( Bassil, NK; Bou Saba, TG; Ohanian, MLK, 2022)
"Smoking cessation is a global public health issue."	( Girard, M; Lacroix, A; Lourmière, G; Nubukpo, P, 2022)
"Smoking cessation is recommended as a key intervention for chronic obstructive pulmonary disease (COPD) smokers."	( Bai, XX; Liao, YH; Liu, JP; Robinson, N; Tang, WT; Wang, J; Zhang, H; Zhang, YY, 2022)
"Tobacco smoking cessation is associated with improvements in mental health."	( Brose, LS; Brown, J; Cox, S; Kock, L; McNeill, A; Robson, D; Shahab, L; Tattan-Birch, H, 2023)
"Tobacco smoking cessation is associated with improvements in mental health."	( Brose, LS; Brown, J; Cox, S; Kock, L; McNeill, A; Robson, D; Shahab, L; Tattan-Birch, H, 2023)
"Smoking cessation is expected to improve vascular endothelial function."	( Higashi, Y, 2023)

Excerpt	Reference
"Smoking cessation has immediate and major health benefits for all individuals."	( Stillman, FA, 1995)
"Smoking cessation has received wide attention from the public and medical communities; it is complex and has several interwoven factors to be considered."	( Hunter, DA; Thompson, GH, 1998)
"Smoking cessation has different consequences for cardiovascular risk factors in men and women."	( Bartholomew, HC; Knuiman, MW, 1998)
"Attempts at smoking cessation have been correlated with severe withdrawal symptoms, including intense cigarette cravings, anxiety, and depressed mood."	( Field, T; Hart, S; Hernandez-Reif, M, 1999)
"The outcome of smoking cessation has improved with the availability of proper behavior approaches and medications."	( Jain, M; Talwar, A; Vijayan, VK, 2004)
"Smoking cessation has major health benefits for men and women of all ages."	( Foulds, J, 2006)
"Smoking cessation has been shown to slow lung function decline and to reduce mortality--including deaths due to lung cancer, other respiratory disease (including COPD), and cardiovascular disease."	( Anzueto, A, 2006)
"Smoking cessation has been shown to normalize the coronary endothelial dysfunction in healthy young smokers."	( Goto, D; Hirata, K; Katoh, C; Manabe, O; Morita, K; Naya, M; Tamaki, N; Tsutsui, H; Yoshinaga, K, 2011)
"Smoking cessation has been shown to be effective in randomized controlled trials."	( Hoch, E; Klotsche, J; Muehlig, S; Wittchen, HU, 2011)
"Rates of smoking cessation have not changed in a decade, accentuating the need for novel approaches to prompt quit attempts."	( Alberg, AJ; Carpenter, MJ; Gray, KM; Hughes, JR; Saladin, ME; Wahlquist, AE, 2011)
"It is clear that smoking cessation has positive impacts for both the mother and child, yet many women are still unable to quit due to the addictive properties of nicotine."	( Barra, NG; De Long, NE; Hardy, DB; Holloway, AC, 2014)
"Vaccines for smoking cessation have shown considerable promise in preclinical models, although functional antibody responses induced in humans are only modestly effective in preventing nicotine entry into the brain."	( Clegg, CH; Miller, KD; Roque, R, 2014)
"Smoking cessation has major benefits for both individuals and society, therefore the aim of this study was to evaluate the potential of noribogaine for use as a treatment for nicotine dependence."	( Chang, Q; Hanania, T; Maillet, EL; Mash, DC, 2015)

Excerpt	Reference
"Retention and end-of-treatment smoking cessation rates were best in the medium-frequency (3-week) and high-frequency (2-week) treatment session formats."	( Schmitz, JM; Tate, JC, 1994)
"An algorithm for physician-based treatment for smoking cessation is presented based on the following guidelines: (1) Smokers who are not contemplating cessation need motivational interventions."	( Hughes, JR, 1994)
"The release of bupropion SR as a treatment for smoking cessation may provide clinicians with additional opportunities to address smoking cessation with their patients."	( Goldstein, MG, 1998)
"The use of nicotine patch treatment for smoking cessation effectively attenuated weight gain for successful female quitters compared with placebo-treated quitters."	( Hill, AL; Leischow, SJ; Muramoto, MM; Roe, DJ; Taren, DL, 2000)
"Bupropion is used clinically as a treatment for smoking cessation, but the processes by which it reduces smoking are poorly understood."	( Cousins, MS; de Wit, H; Stamat, HM, 2001)
"Atypical antipsychotic drug treatment enhanced smoking cessation responses to BUP."	( Bregartner, TA; Feingold, A; George, TP; Kosten, TR; Rounsaville, BJ; Termine, A; Vessicchio, JC, 2002)
"We included 111 patients treated for smoking cessation in the Unit Hospital: 84 patients, under the cognitive-behavioural model, were treated with NRT and 27 patients, under the same model, were treated only with gradual nicotine withdrawal without NRT."	( Corominas, J; Godás, T; Marcos, T, 2004)
"Bupropion is an effective treatment for smoking cessation in the indigenous Maori population in New Zealand."	( Beasley, R; Holt, S; Ryder-Lewis, S; Timu-Parata, C; Weatherall, M, 2005)
"All subjects received periodontal treatment and smoking cessation advice as part of an individual, patient-based programme provided by dental hygienists trained in smoking cessation counselling."	( Heasman, L; Heasman, PA; Nasry, HA; Preshaw, PM; Stacey, F; Swan, M, 2006)
"Despite this, NRT remains the standard treatment for smoking cessation in many countries."	( Doggrell, SA, 2007)
"Varenicline, a new treatment for smoking cessation, has demonstrated significantly greater efficacy over placebo and sustained release bupropion (bupropion SR)."	( Aubin, HJ; Billing, CB; Bobak, A; Britton, JR; Gong, J; Oncken, C; Reeves, KR; Williams, KE, 2008)
"Despite the availability of effective treatments for smoking cessation, such as nicotine replacement therapy and bupropion sustained-release (SR), abstinence rates remain less than optimal."	( Ebbert, JO; Hays, JT; Sood, A, 2008)
"Varenicline is a novel treatment for smoking cessation; however, the agent has not been well studied in a population with severe mental illness."	( DiPaula, BA; Thomas, MD, 2009)
"The key areas of treatment focus on smoking cessation, exercise rehabilitation, with supervised therapy if possible, cardiovascular risk prevention with antiplatelet drugs, statins and angiotensin converting enzymes, and correction of atherosclerotic risk factors with well-defined targets (LDL less than 1g/L, HDL greater than 0."	( Bui, HT; Hadj Henni, A; Journet, J; Long, A, 2009)
"Effective behavioral and pharmacologic treatments for smoking cessation are available."	( Herman, AI; Sofuoglu, M, 2010)
"The effects of varenicline treatment for smoking cessation on mental health (MH) stability in veterans with posttraumatic stress disorder (PTSD) was studied."	( Anderson, KD; Campbell, AR, 2010)
"The advent of new pharmacologic treatments for smoking cessation renews the possibility that such a taste aversion approach may be a useful adjunct to smoking cessation treatment."	( Behm, FM; McClernon, FJ; Murugesan, T; Rose, JE, 2010)
" Continuing treatment to aid smoking cessation with active patches promotes recovery from lapses."	( Ferguson, SG; Gitchell, JG; Shiffman, S, 2012)
"A potential new treatment in smoking cessation and relapse prevention is nicotine vaccination which is based on active immunization against the nicotine molecule."	( Brauer, R; Fahim, RE; Hoogsteder, PH; Kalnik, MW; Kessler, PD; Kotz, D; van Schayck, OC; van Spiegel, PI; Viechtbauer, W, 2012)
"Cytisine is an effective treatment for smoking cessation with efficacy comparable to that of other currently licensed treatments."	( Hajek, P; McRobbie, H; Myers, K, 2013)
"Current treatments for smoking cessation have limited efficacy."	( Ameli, N; Fortmann, SP; Killen, JD; Lazzeroni, LC; Murphy, GM; Ryan, HS; Sarginson, JE; Schatzberg, AF, 2015)
"The number needed-to-treat to achieve smoking cessation for 1 patient at 1 year postoperatively was 5."	( Buhrmann, O; Jones, PM; Landry, J; Lee, SM; Morley-Forster, P, 2015)
"A wider diversity of drug treatments to aid smoking cessation is needed to help tailor the most efficacious treatment for different types of smokers."	( Bymaster, FP; Johnson, JE; Levin, ED; Rezvani, AH; Rose, JE; Wells, C, 2015)
"Varenicline (Chantix) is a first-line treatment for smoking cessation but does not produce cessation in many individuals."	( Dunn, KE; Kim, C; Marcus, TF; Schroeder, JR; Umbricht, A; Vandrey, R, 2016)
"The variety of medical treatments for smoking cessation has increased, health professionals are encouraged to use them to assist smoking cessation and tobacco dependence is being described as a 'chronic disease'."	( Carter, A; Gartner, C; Hall, W; Morphett, K, 2017)
"Varenicline tartrate, an approved treatment for smoking cessation, may reduce both drinking and smoking."	( Bold, KW; Fucito, LM; Gueorguieva, R; Jatlow, P; Muvvala, S; O'Malley, SS; Ockert, DM; Petrakis, I; Piepmeier, ME; Wu, R; Zweben, A, 2018)
"Approved pharmacological treatments for smoking cessation are marginally effective, underscoring the need for improved pharmacotherapies."	( Cinciripini, PM; Green, CE; Kosten, TR; Meininger, JC; Minnix, JA; Newton, TF; Yammine, L, 2018)
"Current treatments for smoking cessation are not effective for most smokers."	( Emamian, MH; Ghorbani Behnam, S; Mousavi, SA, 2019)
"The first-line treatments for smoking cessation are nicotine replacement therapy and varenicline."	( Davies, NM; Itani, T; Jones, T; Martin, RM; Munafò, MR; Taylor, AE; Taylor, GM; Thomas, KH; Windmeijer, F, 2020)
"Approved pharmacological treatments for smoking cessation are modestly effective, underscoring the need for improved pharmacotherapies."	( de Dios, C; Green, CE; Kosten, TR; Lane, SD; Schmitz, JM; Suchting, R; Verrico, CD; Yammine, L, 2021)
"Varenicline is an effective treatment for smoking cessation."	( Boezen, HM; Bos, JHJ; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B, 2022)
"The efficacy of the current treatments for smoking cessation is modest, and these treatments have no clinically meaningful impact on mitigating PCWG."	( Alibhai, H; Cinciripini, PM; Kosten, TR; Lane, SD; Schmitz, JM; Suchting, R; Verrico, CD; Versace, F; Weaver, MF; Webber, HE; Yammine, L, 2023)

Timeframe	Studies, This Condition (%)	All Conditions %
pre-1990	9 (0.12)	23.3326
1990's	945 (12.68)	12.5806
2000's	2583 (34.67)	18.1394
2010's	3063 (41.11)	28.8240
2020's	850 (11.41)	9.53

Drug	Relationship Strength	Studies	Trials
gamma-aminobutyric acid	medium	16	6
5-hydroxytryptophan	low	1	0
acetic acid	medium	4	3
acetaldehyde	medium	3	1
ammonium hydroxide	medium	2	1
benzene	low	1	0
carbon monoxide	medium	441	216
formic acid	low	1	0
methane	low	1	0
citric acid, anhydrous	medium	2	2
chlorine	medium	1	1
salicylic acid	low	1	0
nornicotine	low	3	0
norcotinine	low	2	0
bw 306u	medium	5	1
creatine	low	1	0
cytosine	low	1	0
lactic acid	medium	3	2
formaldehyde	medium	3	1
glycine	medium	1	1
glycerol	medium	7	3
hydrogen carbonate	low	1	0
dalteparin	low	2	0
iodine	low	4	0
dihydroxyphenylalanine	low	1	0
kynurenine	low	1	0
methanol	low	4	0
melatonin	medium	2	1
niacin	low	4	0
nitrates	medium	10	1
nitrites	low	2	0
propylene glycol	medium	5	1
pyridoxine	medium	1	1
taurine	low	2	0
uric acid	low	5	0
urea	low	1	0
8-hydroxy-2-(di-n-propylamino)tetralin	low	1	0
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	medium	1	1
menthol	medium	134	17
1-anilino-8-naphthalenesulfonate	low	1	0
n-methyl-3,4-methylenedioxyamphetamine	low	1	0
3-hydroxybenzylhydrazine	low	1	0
homovanillic acid	low	1	0
phenytoin	low	1	0
hydroxyindoleacetic acid	low	2	0
acetaminophen	low	2	0
albuterol	low	11	0
alendronate	low	1	0
am 251	low	3	0
theophylline	low	26	0
dan 2163	low	1	0
amlodipine	low	1	0
antipyrine	medium	1	1
aspirin	medium	110	9
azathioprine	low	3	0
baclofen	medium	5	2
benzo(a)pyrene	low	2	0
buspirone	medium	9	5
caffeine	medium	21	7
carvedilol	medium	1	1
celecoxib	medium	2	1
cetirizine	low	1	0
chloroquine	low	1	0
chlorpromazine	low	1	0
chlorthalidone	low	1	0
cilostazol	low	15	0
cimetidine	medium	2	2
citalopram	medium	2	1
clofibric acid	low	2	0
clomipramine	low	1	0
clonidine	medium	40	9
clotrimazole	low	1	0
dapsone	low	1	0
amphetamine	medium	1	1
dipyridamole	low	1	0
disulfiram	low	3	0
valproic acid	medium	1	1
domperidone	low	1	0
doxepin	low	2	0
eicosapentaenoic acid ethyl ester	low	1	0
fenfluramine	medium	6	3
fenofibrate	medium	1	1
berotek	low	1	0
fentanyl	low	1	0
fluphenazine	medium	1	1
flumazenil	low	6	0
fluorouracil	low	2	0
fluoxetine	medium	21	16
gabapentin	medium	5	4
glyburide	low	1	0
guaifenesin	medium	8	1
haloperidol	medium	2	1
hydralazine	low	2	0
hydrochlorothiazide	low	1	0
hydroxychloroquine	low	4	0
phenelzine	low	1	0
imipramine	low	1	0
indomethacin	low	1	0
isoflurane	low	1	0
ketamine	medium	3	1
ketoprofen	low	1	0
labetalol	medium	1	1
lamotrigine	low	1	0
losartan	medium	2	1
edaravone	medium	1	1
mecamylamine	medium	30	12
mechlorethamine	low	1	0
memantine	medium	2	1
mesalamine	low	3	0
mescaline	low	1	0
metformin	low	8	0
methadone	medium	67	24
methyl salicylate	low	1	0
methylphenidate	medium	12	8
metoclopramide	low	2	0
metoprolol	low	1	0
metronidazole	medium	2	1
metyrapone	low	1	0
midazolam	low	1	0
moclobemide	medium	2	1
modafinil	medium	5	3
clorgyline	low	1	0
nafronyl	low	2	0
activins	low	1	0
neostigmine	medium	2	1
nifedipine	low	3	0
nimodipine	low	1	0
nitroglycerin	low	4	0
norfluoxetine	medium	1	1
nortriptyline	medium	83	18
ondansetron	medium	5	2
oxazepam	low	1	0
oxybutynin	medium	30	17
pentoxifylline	low	9	0
phenacetin	low	1	0
phentermine	low	1	0
pioglitazone	medium	3	1
pirenzepine	low	2	0
prazosin	low	1	0
procarbazine	low	1	0
risperidone	low	1	0
ropinirole	low	1	0
sevoflurane	low	1	0
sibutramine	medium	1	1
sulforaphane	medium	1	1
sulpiride	low	1	0
temazepam	low	1	0
thalidomide	low	1	0
ticlopidine	low	17	0
vigabatrin	low	1	0
corticosterone	low	2	0
prednisolone	medium	7	1
reserpine	low	1	0
thymidine	low	2	0
thyroxine	low	2	0
dextroamphetamine	medium	5	3
spironolactone	low	2	0
prednisone	low	10	0
estrone	medium	2	1
methylprednisolone acetate	low	1	0
dehydroepiandrosterone	medium	7	2
pilocarpine	low	1	0
biguanides	low	1	0
sucrose	medium	6	2
apomorphine	low	2	0
carbostyril	medium	4	3
levodopa	medium	2	1
edetic acid	low	1	0
tyrosine	medium	4	1
adenosine monophosphate	low	2	0
methacholine chloride	low	5	0
methionine	medium	6	1
phenylalanine	medium	2	1
colchicine	low	2	0
n-hexanal	low	1	0
chlorisondamine	low	1	0
mannitol	low	2	0
medroxyprogesterone acetate	low	1	0
valine	medium	6	1
tryptophan	medium	2	2
arginine	medium	3	1
acetonitrile	low	1	0
methylene chloride	low	1	0
propylene oxide	low	1	0
phencyclidine	medium	10	2
tromethamine	low	1	0
acrylic acid	low	1	0
methylprednisolone	low	9	0
isosorbide dinitrate	low	1	0
diethylpropion	low	1	0
quinoxalines	medium	632	154
2-naphthylamine	low	1	0
4-biphenylamine	low	1	0
trehalose	low	1	0
pyridostigmine bromide	low	2	0
1,3-butadiene	low	1	0
acrolein	low	4	0
acrylonitrile	medium	1	1
cyclohexanol	medium	3	3
pyrroles	low	4	0
thiophenes	low	2	0
heptanal	low	1	0
pelargonic acid	low	1	0
quinazolines	low	2	0
isoxazoles	medium	2	1
pyrazines	low	2	0
indopan	low	1	0
ephedrine	medium	1	1
hydrazine	low	1	0
thiocyanate	medium	13	7
galantamine	medium	7	5
indole-3-carbaldehyde	low	1	0
phenylpropanolamine	medium	2	2
alpha-aminopyridine	low	3	0
thiazolidines	low	1	0
psilocybin	medium	9	3
4,6-dinitro-o-cresol	low	1	0
methoxyhydroxyphenylglycol	low	2	0
methamphetamine	medium	7	3
malondialdehyde	medium	13	5
trinitrobenzenesulfonic acid	low	1	0
lithium carbonate	low	1	0
silver acetate	medium	3	1
anatabine	medium	4	2
acetylcysteine	medium	19	10
erythromycin	low	1	0
dehydroepiandrosterone sulfate	low	5	0
isodesmosine	low	1	0
2-acetylpyridine	low	1	0
durapatite	medium	1	1
d-alpha tocopherol	medium	13	3
tocopherols	low	1	0
s,n,n'-tripropylthiocarbamate	medium	194	67
dronabinol	medium	7	1
cladribine	low	1	0
1-hydroxypyrene	medium	2	2
n-methylaspartate	low	1	0
platinum	low	1	0
silver	low	1	0
titanium	low	1	0
cadmium	low	9	0
chromium	low	1	0
helium	medium	4	1
uranium	medium	1	1
magnesium sulfate	low	1	0
silver nitrate	medium	1	1
deuterium	low	1	0
radon	medium	18	3
trolamine salicylate	low	6	0
ferric nitrate	medium	1	1
selegiline	medium	12	11
n'-nitrosonornicotine	medium	5	2
tetradecanoylphorbol acetate	low	1	0
fluorides	low	3	0
lisuride	medium	1	1
bromocriptine	medium	3	1
phenyl acetate	medium	8	4
cetylpyridinium chloride anhydrous	medium	21	2
nonanal	low	2	0
triamcinolone	low	2	0
pregnanolone	medium	2	1
pyrene	medium	1	1
4-methoxyamphetamine	low	2	0
dihydro-beta-erythroidine	low	4	0
glutamic acid	medium	5	1
tramadol	low	2	0
zidovudine	low	1	0
bezafibrate	low	2	0
pirfenidone	low	1	0
7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	medium	2	1
sufentanil	low	1	0
desflurane	low	1	0
propiconazole	low	3	0
paroxetine	medium	3	3
4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone	medium	10	5
atracurium	medium	1	1
nicorandil	low	2	0
fomesafen	medium	6	1
fenoxycarb	low	2	0
lovastatin	low	2	0
pravastatin	medium	2	1
atomoxetine hydrochloride	medium	3	1
raloxifene hydrochloride	low	1	0
mifepristone	low	1	0
fluorodopa f 18	low	1	0
salmeterol xinafoate	low	7	0
ranolazine	low	2	0
clopidogrel	low	16	0
tiagabine	medium	1	1
aripiprazole	medium	4	3
atorvastatin	low	3	0
lamivudine	low	1	0
duloxetine hydrochloride	low	1	0
adenosine	medium	2	1
venlafaxine hydrochloride	medium	4	3
norharman	low	2	0
cephalosporin c	low	1	0
triazoles	low	2	0
fluorodeoxyglucose f18	medium	1	1
sertraline	medium	5	4
acamprosate	low	2	0
lazabemide	medium	1	1
rivastigmine	medium	2	2
fibrinogen	medium	25	9
homocysteine	medium	11	1
melamine phosphate	low	1	0
mci 9038	medium	1	1
gamma-tocopherol	medium	1	1
vitamin b 6	medium	1	1
4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol	medium	14	9
bosentan anhydrous	low	1	0
4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol	low	1	0
epibatidine	low	3	0
methyllycaconitine	low	1	0
ecopipam	medium	1	1
hydroxycotinine	medium	26	10
cotinine-n-oxide	low	1	0
thromboxanes	low	3	0
s-(3-hydroxypropyl)cysteine n-acetate	medium	2	1
pramipexole	medium	1	1
carboxypolymethylene	low	1	0
interleukin-1beta (163-171)	low	1	0
zd 7288	low	1	0
methotrexate	low	1	0
omega-n-methylarginine	low	1	0
ivabradine	low	1	0
febuxostat	low	1	0
aspartame	medium	1	1
amphethinile	medium	1	1
docetaxel anhydrous	low	1	0
levofloxacin	low	1	0
ezetimibe	low	1	0
cilomilast	low	1	0
telbivudine	low	1	0
torcetrapib	low	1	0
angiotensin ii	medium	6	3
erlotinib hydrochloride	medium	2	1
dexketoprofen trometamol	low	1	0
anabasine	medium	6	1
beta-methyl-6-chloromelatonin	low	1	0
benzofurans	low	2	0
ibogaine	low	1	0
trimethoprim, sulfamethoxazole drug combination	low	1	0
povidone-iodine	low	1	0
n-acetylneuraminic acid	low	1	0
fibrin	medium	1	1
bradykinin	low	1	0
elastin	low	4	0
oxytocin	medium	3	2
theanine	medium	2	1
tartaric acid	low	1	0
inositol 3-phosphate	low	1	0
ergonovine	low	1	0
tibolone	low	2	0
tretinoin	medium	3	2
retinol	low	4	0
tacrolimus	low	1	0
cocaine	medium	20	4
eicosapentaenoic acid	low	3	0
lycopene	low	1	0
2-butenal	low	1	0
alitretinoin	medium	1	1
roflumilast	low	2	0
sodium bicarbonate	low	1	0
deformylflustrabromine	low	2	0
stilbenes	low	1	0
cannabidiol	medium	2	1
buprenorphine	medium	13	2
gw9662	low	1	0
s 1033	low	1	0
propylthiouracil	medium	1	1
cotinine	medium	516	228
curcumin	low	2	0
methimazole	low	1	0
capsaicin	medium	3	1
enclomiphene	low	2	0
D-fructopyranose	medium	12	10
digoxin	medium	3	1
tamoxifen	low	3	0
ranitidine	low	1	0
lithium	low	1	0
zineb	low	1	0
maneb	low	1	0
thiophanate	low	1	0
raclopride	medium	3	2
quinine	medium	3	1
thymidine glycol	low	1	0
cystine	medium	1	1
bp 897	low	1	0
freedom	low	7	0
oxalylglycine	low	1	0
noribogaine	low	1	0
tolcapone	medium	1	1
quercetin	low	1	0
bilirubin	medium	2	1
dinoprostone	medium	2	1
dinoprost	medium	10	2
vitexin	low	1	0
apigenin	low	1	0
calcitriol	low	3	0
beta carotene	low	8	0
leukotriene b4	medium	1	1
thromboxane a2	medium	5	3
6-ketoprostaglandin f1 alpha	medium	3	1
11-dehydro-thromboxane b2	medium	2	1
zeaxanthin	low	1	0
harmine	medium	3	1
pulmicort	medium	5	2
kava	medium	1	1
lutein	low	2	0
harman	medium	1	1
humulene	medium	23	5
anandamide	low	2	0
8-epi-prostaglandin f2alpha	medium	9	2
isotretinoin	medium	4	2
fondaparinux	low	1	0
2,3-dinor-6-ketoprostaglandin f1alpha	medium	3	1
thromboxane b2	medium	5	2
2,3-dinor-thromboxane b2	low	2	0
4-hydroxy-2-nonenal	low	1	0
phenylephrine hydrochloride	medium	4	3
nabilone	low	1	0
naloxone	low	4	0
sirolimus	low	1	0
lobeline	medium	5	1
morphine	low	4	0
a 85380	low	2	0
sb 277011	low	1	0
fluticasone	medium	9	2
iloprost	low	9	0
lead	medium	4	1
rubidium	low	1	0
arsenic	medium	2	1
naltrexone	medium	70	40
dextromethorphan	low	1	0
indinavir sulfate	low	1	0
fumarates	low	1	0
cysteine	medium	2	2
heroin	low	1	0
pregabalin	medium	1	1
tiotropium bromide	medium	15	1
aliskiren	low	1	0
selenium	low	6	0
radium	medium	11	2
4-oxo-2-nonenal	low	1	0
glucuronyl glucosamine glycan sulfate	low	1	0
nitrofurantoin	low	1	0
am 404	low	1	0
helium-3 atom	low	2	0
hypericum	medium	7	5
chlorhexidine	medium	2	1
radafaxine	low	5	0
mocetinostat	medium	4	2
ticagrelor	medium	1	1
rivaroxaban	low	1	0
s 24795	low	1	0
tofacitinib	low	1	0
n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide	low	2	0
dianicline	medium	7	1
f-a 85380	medium	1	1
ro 16-0154	low	1	0
palovarotene	low	1	0
n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide	medium	2	1
buprenorphine, naloxone drug combination	low	1	0
naluzotan	low	1	0
sitagliptin phosphate	low	1	0
lisdexamfetamine dimesylate	medium	1	1
lorcaserin	medium	3	2
technetium tc 99m exametazime	low	1	0
scopolamine hydrobromide	low	1	0
pituitrin	low	1	0
sazetidine-a	low	2	0
thienopyridine	low	1	0
phytosterols	low	1	0
enerbol	low	1	0
clove	low	1	0
acid phosphatase	low	2	0
jaw	low	1	0
desmosine	low	1	0
gsk 1034702	medium	2	1
cholecystokinin	medium	1	1
atrial natriuretic factor	low	1	0
gastrins	low	1	0
beta-endorphin	medium	2	1
neuropeptide y	medium	2	1
glucagon-like peptide 1	medium	5	3
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ilys-prolyl-alaninamide	low	1	0
incretins	low	1	0
c-peptide	medium	1	1
endothelin-1	low	3	0
phosphatidylcholines	low	1	0
(9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	medium	5	2
chitosan	low	2	0
sodium oxybate	low	1	0
ro13-9904	low	1	0
sodium ethylxanthate	low	2	0
s-adenosylmethionine	medium	1	1
insulin, isophane	medium	1	1
quetiapine fumarate	low	1	0
cardiovascular agents	medium	81	15

Protein Targets (2,842)

Protein	Potency Measurements	Inhibition Measurements	Activation Measurements	Drugs
IDH1	47	0	0	47
chromobox protein homolog 1	71	0	0	71
geminin	117	0	0	117
Chain B, pheromone binding protein	0	0	1	1
Chain A, pheromone binding protein	0	0	1	1
Chain A, JmjC domain-containing histone demethylation protein 3A	28	0	0	28
Chain A, RNA-directed RNA polymerase NS5	0	1	0	1
acid sphingomyelinase	8	0	0	8
thioredoxin reductase	85	0	0	85
USP1 protein, partial	61	0	0	61
TDP1 protein	133	0	0	133
vitamin D3 receptor isoform VDRA	47	0	0	47
importin subunit beta-1 isoform 1	13	0	0	13
flap endonuclease 1	32	0	0	32
serine/threonine-protein kinase PLK1	9	0	0	9
snurportin-1	13	0	0	13
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	21	0	0	21
GTP-binding nuclear protein Ran isoform 1	9	0	0	9
DNA polymerase eta isoform 1	9	0	0	9
DNA polymerase iota isoform a (long)	36	0	0	36
urokinase-type plasminogen activator precursor	18	0	0	18
plasminogen precursor	18	0	0	18
urokinase plasminogen activator surface receptor precursor	18	0	0	18
DNA polymerase kappa isoform 1	29	0	0	29
fibroblast growth factor 22 isoform 1 precursor	0	0	0	1
Mitogen-activated protein kinase 13	0	2	2	4
Beta-lactamase	0	4	0	4
Transthyretin	0	2	4	7
Fatty acid-binding protein, intestinal	0	5	2	7
Fatty acid-binding protein, adipocyte	0	1	1	2
Cyclin-A2	0	2	0	2
Cannabinoid receptor 1	0	11	5	16
Cyclin-dependent kinase 2	0	4	5	9
Choline O-acetyltransferase	0	2	0	2
Mitogen-activated protein kinase 12	0	2	2	4
Guanine nucleotide-binding protein G	15	0	0	15
Fatty acid-binding protein 5	0	0	1	1
Fatty acid-binding protein 5	0	0	2	2
Mitogen-activated protein kinase 11	0	2	3	5
Mitogen-activated protein kinase 14	0	8	4	12
Luciferase	53	0	0	53
RAR-related orphan receptor gamma	113	0	0	113
GLI family zinc finger 3	130	0	0	130
AR protein	156	0	0	156
nuclear receptor subfamily 1, group I, member 3	109	0	0	109
progesterone receptor	83	0	0	83
glucocorticoid receptor [Homo sapiens]	126	0	0	126
retinoic acid nuclear receptor alpha variant 1	124	0	0	124
retinoid X nuclear receptor alpha	96	0	0	96
farnesoid X nuclear receptor	68	0	0	68
pregnane X nuclear receptor	111	0	0	111
estrogen nuclear receptor alpha	181	0	0	181
peroxisome proliferator-activated receptor delta	79	0	0	79
peroxisome proliferator activated receptor gamma	93	0	0	93
vitamin D (1,25- dihydroxyvitamin D3) receptor	78	0	0	78
aryl hydrocarbon receptor	59	0	0	59
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	83	0	0	83
activating transcription factor 6	44	0	0	44
v-jun sarcoma virus 17 oncogene homolog (avian)	60	0	0	60
Histone H2A.x	42	0	0	42
thyroid hormone receptor beta isoform 2	111	0	0	111
heat shock protein beta-1	41	0	0	41
nuclear factor erythroid 2-related factor 2 isoform 1	113	0	0	113
Cellular tumor antigen p53	97	0	0	97
aldehyde dehydrogenase 1 family, member A1	86	0	0	86
Chain A, Beta-lactamase	28	0	0	28
bromodomain adjacent to zinc finger domain 2B	26	0	0	26
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	45	0	0	45
Gamma-aminobutyric acid receptor subunit pi	72	24	3	99
Stromelysin-1	0	3	2	5
Gamma-aminobutyric acid receptor subunit beta-1	72	24	3	99
Gamma-aminobutyric acid receptor subunit delta	72	24	3	99
Gamma-aminobutyric acid receptor subunit gamma-2	72	24	5	101
Gamma-aminobutyric acid receptor subunit alpha-5	72	24	3	99
Gamma-aminobutyric acid receptor subunit alpha-3	72	24	3	99
Gamma-aminobutyric acid receptor subunit gamma-1	72	24	3	99
Gamma-aminobutyric acid receptor subunit alpha-2	72	24	3	99
Gamma-aminobutyric acid receptor subunit alpha-4	72	24	3	99
Gamma-aminobutyric acid receptor subunit gamma-3	72	24	3	99
Gamma-aminobutyric acid receptor subunit alpha-6	72	24	3	99
Gamma-aminobutyric acid receptor subunit alpha-1	72	26	5	103
Gamma-aminobutyric acid receptor subunit beta-3	72	24	3	99
Gamma-aminobutyric acid receptor subunit beta-2	72	24	5	101
GABA theta subunit	72	24	3	99
Gamma-aminobutyric acid receptor subunit epsilon	72	24	3	99
mitogen-activated protein kinase 1	41	0	0	41
Transient receptor potential cation channel subfamily A member 1	0	0	6	7
Voltage-dependent calcium channel gamma-2 subunit	64	0	0	64
Glutamate receptor 2	65	5	4	74
Chain A, HADH2 protein	44	0	0	44
Chain B, HADH2 protein	44	0	0	44
ClpP	6	0	0	6
pregnane X receptor	25	0	0	25
SMAD family member 2	46	0	0	46
SMAD family member 3	46	0	0	46
apical membrane antigen 1, AMA1	10	0	0	10
estrogen receptor 2 (ER beta)	70	0	0	70
regulator of G-protein signaling 4	62	0	0	62
estrogen-related nuclear receptor alpha	144	0	0	144
nuclear factor erythroid 2-related factor 2 isoform 2	36	0	0	37
cytochrome P450 3A4 isoform 1	72	0	0	72
Neutrophil cytosol factor 1	0	3	0	3
Nuclear receptor ROR-gamma	27	3	3	33
15-lipoxygenase, partial	24	0	0	24
NFKB1 protein, partial	29	0	0	29
pyruvate kinase	7	0	0	7
muscarinic acetylcholine receptor M1	51	0	0	51
pyruvate kinase PKM isoform b	5	0	0	5
Ornithine decarboxylase	5	0	0	6
4-aminobutyrate aminotransferase, mitochondrial	0	2	1	4
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	42	0	0	42
BRCA1	2	0	0	2
histone deacetylase 9 isoform 3	14	0	0	14
lethal factor (plasmid)	34	0	0	34
UDP-glucuronosyltransferase 1A4	0	3	0	12
Microtubule-associated protein tau	58	0	0	58
Transient receptor potential cation channel subfamily A member 1	0	1	3	4
5-hydroxytryptamine receptor 2C	0	35	5	41
5-hydroxytryptamine receptor 2A	0	37	6	44
5-hydroxytryptamine receptor 1A	0	64	8	75
5-hydroxytryptamine receptor 1B	0	48	4	53
5-hydroxytryptamine receptor 1D	0	17	4	22
5-hydroxytryptamine receptor 1F	0	17	4	22
5-hydroxytryptamine receptor 2B	0	31	5	36
5-hydroxytryptamine receptor 6	0	7	4	11
Sodium-dependent serotonin transporter	0	70	9	79
Sodium-dependent serotonin transporter	0	27	5	33
5-hydroxytryptamine receptor 7	0	14	4	18
5-hydroxytryptamine receptor 5A	0	7	4	11
5-hydroxytryptamine receptor 5B	0	7	4	11
5-hydroxytryptamine receptor 3A	0	13	5	18
5-hydroxytryptamine receptor 4	0	8	4	13
5-hydroxytryptamine receptor 3B	0	13	5	18
interleukin 8	21	0	0	21
acetylcholinesterase	50	0	0	50
hypoxia-inducible factor 1 alpha subunit	44	0	0	44
cytochrome P450 family 3 subfamily A polypeptide 4	89	0	0	89
G	62	0	0	62
thyroid stimulating hormone receptor	53	0	0	53
nuclear receptor ROR-gamma isoform 1	57	0	0	57
Interferon beta	81	0	0	81
HLA class I histocompatibility antigen, B alpha chain	62	0	0	62
Inositol hexakisphosphate kinase 1	62	0	0	62
ATPase family AAA domain-containing protein 5	48	0	0	48
Ataxin-2	66	0	0	66
cytochrome P450 2C9, partial	62	0	0	62
Solute carrier organic anion transporter family member 2A1	0	1	0	6
phosphopantetheinyl transferase	55	0	0	55
euchromatic histone-lysine N-methyltransferase 2	130	0	0	130
mu-type opioid receptor isoform MOR-1	0	0	3	3
5-hydroxytryptamine receptor 2A	0	0	3	3
Cytochrome P450 3A4	0	51	4	64
5-hydroxytryptamine receptor 1A	0	27	13	41
Neuronal acetylcholine receptor subunit alpha-4	6	23	9	40
Cytochrome P450 2C9	0	42	3	48
Neuronal acetylcholine receptor subunit beta-2	6	22	9	39
D(2) dopamine receptor	0	63	11	84
Alpha-1B adrenergic receptor	0	50	5	55
Translocator protein	0	9	1	10
D	0	24	0	25
D(3) dopamine receptor	0	26	1	27
Alpha-2B adrenergic receptor	0	24	4	29
D(2) dopamine receptor	0	11	0	11
Alpha-2C adrenergic receptor	0	24	4	29
Alpha-2A adrenergic receptor	0	26	4	31
Alpha-1D adrenergic receptor	0	31	5	37
Sodium-dependent dopamine transporter	0	26	3	29
Alpha-1D adrenergic receptor	0	50	4	58
5-hydroxytryptamine receptor 1D	0	6	0	6
5-hydroxytryptamine receptor 1B	0	7	2	9
5-hydroxytryptamine receptor 2C	0	64	7	71
5-hydroxytryptamine receptor 7	0	17	1	18
Alpha-1A adrenergic receptor	0	17	6	29
Alpha-1B adrenergic receptor	0	13	4	21
Alpha-1A adrenergic receptor	0	58	6	64
5-hydroxytryptamine receptor 5A	0	6	0	6
5-hydroxytryptamine receptor 6	0	47	1	51
5-hydroxytryptamine receptor 7	0	17	0	17
D(2) dopamine receptor	0	42	6	50
D	0	3	0	3
5-hydroxytryptamine receptor 2A	0	2	0	2
Sigma non-opioid intracellular receptor 1	0	52	2	54
Lysosomal alpha-glucosidase	0	2	0	2
Transporter	0	18	2	21
ATP-dependent phosphofructokinase	62	0	0	62
Chain A, Avidin	0	0	2	2
Chain A, Avidin	0	0	2	2
Chain B, Avidin	0	0	2	2
cytochrome P450 2D6	82	0	0	82
Acetylcholine receptor subunit alpha	0	9	4	13
Acetylcholine receptor subunit alpha	0	5	1	6
Neuronal acetylcholine receptor subunit alpha-3	0	14	7	23
Acetylcholine receptor subunit gamma	0	8	4	12
Acetylcholine receptor subunit beta	0	8	4	12
Neuronal acetylcholine receptor subunit alpha-2	0	8	4	13
Neuronal acetylcholine receptor subunit beta-3	0	6	5	12
Neuronal acetylcholine receptor subunit beta-4	0	14	7	23
Neuronal acetylcholine receptor subunit beta-2	0	21	7	31
Neuronal acetylcholine receptor subunit alpha-5	0	5	4	10
Neuronal acetylcholine receptor subunit beta-4	0	10	4	16
Neuronal acetylcholine receptor subunit alpha-3	0	10	5	16
Neuronal acetylcholine receptor subunit alpha-7	0	11	6	17
Neuronal acetylcholine receptor subunit alpha-6	0	7	5	13
Neuronal acetylcholine receptor subunit alpha-9	0	5	4	10
Neuronal acetylcholine receptor subunit alpha-4	0	20	7	29
Neuronal acetylcholine receptor subunit alpha-7	0	13	8	22
Acetylcholine receptor subunit delta	0	8	4	12
Neuronal acetylcholine receptor subunit alpha-10	0	5	4	10
caspase 7, apoptosis-related cysteine protease	26	0	0	26
thyroid stimulating hormone receptor	63	0	0	63
caspase-3	26	0	0	26
thyrotropin-releasing hormone receptor	13	0	0	13
Caspase-7	14	0	0	14
caspase-3	14	0	0	14
ATAD5 protein, partial	56	0	0	56
GLS protein	55	0	0	55
Smad3	36	0	0	36
EWS/FLI fusion protein	72	0	0	73
peripheral myelin protein 22	65	0	0	65
ATP-binding cassette sub-family C member 3	0	116	0	116
Multidrug resistance-associated protein 4	0	118	0	122
Solute carrier family 22 member 6	0	13	0	14
Carbonic anhydrase 12	0	14	1	25
UDP-glucuronosyltransferase 1A9	0	1	0	7
Bile salt export pump	0	26	0	26
Bile salt export pump	0	159	0	159
Cytochrome P450 2B1	0	2	0	3
Cytochrome P450 1A1	0	0	0	1
Carbonic anhydrase 1	0	31	1	46
Carbonic anhydrase 2	0	36	5	54
Myoglobin	0	1	0	1
Cytochrome P450 1A1	0	7	2	10
Cytochrome P450 1A2	0	18	3	26
Prostaglandin G/H synthase 1	0	11	0	12
Carbonic anhydrase 3	0	14	1	22
Cytochrome P450 2D6	0	39	3	47
Polyunsaturated fatty acid lipoxygenase ALOX15	0	11	0	11
Sulfotransferase 1A1	0	0	0	1
UDP-glucuronosyltransferase 1-6	0	3	0	6
Arachidonate 5-lipoxygenase-activating protein	0	4	0	4
UDP-glucuronosyltransferase 1A1	0	5	0	9
Carbonic anhydrase 4	0	21	1	31
Prostaglandin G/H synthase 1	0	15	0	16
Carbonic anhydrase 6	0	14	1	24
Carbonic anhydrase 5A, mitochondrial	0	15	3	28
Prostaglandin G/H synthase 2	0	19	4	25
Carbonic anhydrase 7	0	14	1	24
Cytochrome P450 2J2	0	23	0	24
Carbonic anhydrase 9	0	17	2	30
Canalicular multispecific organic anion transporter 1	0	111	0	111
Carbonic anhydrase 15	0	14	0	19
Carbonic anhydrase 13	0	9	0	17
Carbonic anhydrase 14	0	13	1	24
Carbonic anhydrase 5B, mitochondrial	0	15	1	26
toxin B	0	0	0	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Class Iii Chitinase Chia1	0	1	0	1
Chain A, Carbonic anhydrase 13	0	1	0	1
Chain A, Carbonic anhydrase II	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase	0	1	0	1
Chain B, Carbonic anhydrase	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Carbonic anhydrase	0	0	0	5
Carbonic anhydrase	0	7	0	7
GALC protein	16	0	0	16
Carbonic anhydrase	0	6	0	6
Carbonic anhydrase	0	5	0	5
arylsulfatase A	54	0	0	54
Carbonic anhydrase	0	5	0	5
Bloom syndrome protein isoform 1	42	0	0	42
thyroid hormone receptor beta isoform a	38	0	0	38
survival motor neuron protein isoform d	48	0	0	48
muscleblind-like protein 1 isoform 1	20	0	0	20
Carbonic anhydrase	0	4	0	4
Prolyl endopeptidase	0	3	0	3
Carbonic anhydrase-related protein 11	0	1	0	3
Glycogen phosphorylase, muscle form	0	3	0	3
Renin	0	5	1	6
Carbonic anhydrase 2	0	3	0	3
Cathepsin B	0	1	0	1
Steryl-sulfatase	0	3	0	4
Polyunsaturated fatty acid 5-lipoxygenase	0	9	0	9
Cytochrome P450 2C8	0	13	0	13
Cytochrome P450 2A6	0	13	2	15
Androgen receptor	0	27	0	28
Cytochrome P450 2B6	0	8	0	10
Carbonic anhydrase 5A, mitochondrial	0	2	0	2
Adenosine receptor A1	0	14	2	21
Serum paraoxonase/arylesterase 1	0	4	0	4
Dipeptidyl peptidase 4	0	3	0	4
Endochitinase	0	1	0	1
Adenosine receptor A2a	0	11	4	22
Delta-type opioid receptor	0	20	2	26
Cytochrome P450 2C19	0	25	1	29
Delta-type opioid receptor	0	22	5	29
Mu-type opioid receptor	0	25	6	34
Carbonic anhydrase	0	10	0	14
Kappa-type opioid receptor	0	14	3	19
Carbonic anhydrase	0	1	0	1
D(1A) dopamine receptor	16	2	0	18
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	2	1	3
Carbonic anhydrase	0	5	0	9
Cholinesterase	0	11	1	12
Carbonic anhydrase	0	4	0	4
Mu-type opioid receptor	0	20	4	25
Fatty-acid amide hydrolase 1	0	6	0	7
Beta-carbonic anhydrase 1	0	5	0	5
Carbonic anhydrase 2	0	5	0	5
Glutamate receptor ionotropic, NMDA 2B	0	25	4	34
Squalene synthase	0	2	0	2
Carbonic anhydrase	0	2	0	2
Carbonic anhydrase, alpha family	0	6	0	6
Carbonic anhydrase	0	5	0	9
Carbonic anhydrase 3	0	4	0	4
Carbonic anhydrase	0	3	0	8
Carbonic anhydrase	0	5	0	10
Carbonic anhydrase	0	6	0	6
Sigma intracellular receptor 2	0	11	0	11
Delta carbonic anhydrase	0	6	0	6
Sigma non-opioid intracellular receptor 1	0	16	0	16
Renin	0	2	0	2
Carbonic anhydrase	0	5	0	9
Endochitinase A1	0	1	0	1
Multidrug resistance-associated protein 1	0	2	0	2
Carbonic anhydrase 13	0	7	1	10
Carbonic anhydrase 4	0	7	0	7
Acidic mammalian chitinase	0	1	0	1
Carbonic anhydrase 7	0	1	0	1
Carbonic anhydrase	0	2	0	2
Carbonic anhydrase	0	1	0	1
Carbonic anhydrase 2, isoform A	0	1	0	1
Free fatty acid receptor 3	0	0	1	1
Free fatty acid receptor 2	0	1	1	2
Tyrosine-protein kinase Lck	0	7	4	11
Tyrosine-protein kinase Fyn	0	9	4	13
Fibrinogen C domain-containing protein 1	0	1	0	1
Gonadotropin-releasing hormone receptor	0	1	1	2
Chain A, 2-oxoglutarate Oxygenase	46	0	0	46
Chain A, ATP-DEPENDENT DNA HELICASE Q1	8	0	0	8
dopamine D1 receptor	9	0	0	9
Thrombopoietin	22	0	0	22
D(1A) dopamine receptor	39	0	0	39
Histone deacetylase 3	0	9	0	9
Histone deacetylase 4	0	8	0	8
Histone deacetylase 1	0	12	0	12
Histone deacetylase 7	0	8	0	8
Histone deacetylase 2	0	12	0	12
Polyamine deacetylase HDAC10	0	7	0	7
Histone deacetylase 11	0	8	0	8
Histone deacetylase 8	0	9	0	9
Histone deacetylase 6	0	10	0	10
Histone deacetylase 9	0	7	0	7
Histone deacetylase 5	0	8	0	8
lamin isoform A-delta10	111	0	0	111
Choline O-acetyltransferase	0	1	0	1
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	63	0	0	63
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain B, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, tRNA (guanine-N(1)-)-methyltransferase	0	0	1	1
Chain A, Uncharacterized protein MJ0883	0	0	1	1
signal transducer and activator of transcription 6, interleukin-4 induced	2	0	0	2
NPYLR7B	0	0	4	4
glycogen synthase kinase-3 beta isoform 1	0	0	2	2
high affinity choline transporter 1 isoform a	0	1	0	1
Sodium/nucleoside cotransporter 1	0	2	0	2
Calcium dependent protein kinase	0	1	0	1
Mitogen-activated protein kinase kinase kinase 7	0	0	4	4
Sodium/nucleoside cotransporter 2	0	2	0	2
Rap guanine nucleotide exchange factor 3	10	0	0	10
Purine nucleoside phosphorylase	0	3	0	4
Epidermal growth factor receptor	0	17	3	20
Phosphoglycerate kinase 1	0	1	0	1
Adenosine deaminase	0	0	0	1
Avidin	0	0	1	1
Adenosine deaminase	0	0	0	1
Glyceraldehyde-3-phosphate dehydrogenase	0	2	0	2
Receptor tyrosine-protein kinase erbB-2	0	9	2	11
Insulin receptor	0	1	3	5
Phosphoglycerate kinase 2	0	1	0	1
Heat shock protein HSP 90-alpha	0	1	2	3
Platelet-derived growth factor receptor beta	0	1	3	5
Adenosine receptor A3	0	27	3	31
Heat shock 70 kDa protein 1A	0	1	0	1
Heat shock cognate 71 kDa protein	0	0	1	1
Fibroblast growth factor receptor 1	0	0	3	4
Inosine-5'-monophosphate dehydrogenase 2	0	2	2	4
Endoplasmin	0	1	1	2
Inosine-5'-monophosphate dehydrogenase 1	0	1	0	1
Fibroblast growth factor receptor 2	0	0	2	3
Fibroblast growth factor receptor 4	0	0	2	3
Fibroblast growth factor receptor 3	0	0	2	3
Streptavidin	0	0	1	1
Adenosylhomocysteinase	0	1	0	3
Adenosine receptor A3	0	4	0	4
Adenosine receptor A2a	0	13	7	23
Adenosine receptor A2b	0	4	1	8
Adenosine receptor A2b	0	4	2	8
Adenylate kinase 2, mitochondrial	0	2	0	3
Adenosine receptor A1	0	15	5	25
Adenylate kinase isoenzyme 1	0	2	0	3
Phosphatidylinositol 4-kinase alpha	0	3	0	4
Adenosine receptor A1	0	2	1	3
Adenosine kinase	0	0	3	4
Adenosine deaminase	0	0	0	1
Equilibrative nucleoside transporter 2	0	2	0	2
Phosphatidylinositol 4-kinase type 2-beta	0	3	0	4
Histone-lysine N-methyltransferase, H3 lysine-79 specific	0	1	0	1
Equilibrative nucleoside transporter 1	0	4	0	4
Phosphatidylinositol 4-kinase type 2-alpha	0	3	0	4
Solute carrier family 28 member 3	0	2	0	2
Adenosine kinase	0	1	0	2
Phosphatidylinositol 4-kinase beta	0	3	2	6
5-methylthioadenosine/S-adenosylhomocysteine deaminase	0	0	0	1
Adenosine transporter 1	0	0	0	1
Chain A, Glycogen Phosphorylase B	0	0	1	1
Chain B, Glycogen Phosphorylase B	0	0	1	1
Chain A, ADP-dependent glucokinase	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, phosphodiesterase-nucleotide pyrophosphatase	0	1	0	1
Chain A, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
Chain B, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
Chain A, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1	0	1	0	1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1	0	1	0	1
5'-AMP-activated protein kinase subunit beta-2	0	0	1	2
Transient receptor potential cation channel subfamily M member 2	0	2	0	2
Alcohol dehydrogenase E chain	0	1	0	1
Alcohol dehydrogenase S chain	0	1	0	1
L-lactate dehydrogenase A chain	0	3	1	4
Adenylate kinase isoenzyme 1	0	0	0	1
Fructose-1,6-bisphosphatase 1	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	4	0	5
Fructose-1,6-bisphosphatase 1	0	2	0	2
2-dehydropantoate 2-reductase	0	1	1	2
Inosine-5'-monophosphate dehydrogenase	0	1	0	1
Proto-oncogene tyrosine-protein kinase Src	0	5	3	8
Amine oxidase [flavin-containing] B	0	13	0	14
5'-nucleotidase	0	0	0	1
GTP:AMP phosphotransferase AK3, mitochondrial	0	0	0	1
P2Y purinoceptor 2	0	0	1	1
P2Y purinoceptor 1	0	0	1	1
P2Y purinoceptor 1	0	0	1	1
5'-AMP-activated protein kinase subunit gamma-1	0	0	5	6
5'-AMP-activated protein kinase catalytic subunit alpha-2	0	0	3	4
Adenylate kinase 2, mitochondrial	0	0	3	4
Glycine--tRNA ligase	0	1	0	1
5'-AMP-activated protein kinase catalytic subunit alpha-1	0	0	5	6
Adenosine deaminase-like protein	0	0	0	1
Protease	0	9	3	14
P2Y purinoceptor 11	0	0	1	1
Histamine H3 receptor	0	2	0	2
5'-AMP-activated protein kinase subunit gamma-3	0	0	1	2
5'-AMP-activated protein kinase subunit gamma-2	0	0	4	5
5'-AMP-activated protein kinase subunit beta-1	0	0	2	3
glp-1 receptor, partial	33	0	0	33
Beta-2 adrenergic receptor	0	19	9	28
Beta-1 adrenergic receptor	0	21	7	28
60 kDa chaperonin	0	5	0	5
60 kDa heat shock protein, mitochondrial	0	5	0	5
Beta-3 adrenergic receptor	0	21	6	27
10 kDa heat shock protein, mitochondrial	0	5	0	5
Thiosulfate sulfurtransferase	0	5	0	5
Beta-2 adrenergic receptor	0	0	2	6
60 kDa chaperonin	0	6	0	6
10 kDa chaperonin	0	6	0	6
Beta-2 adrenergic receptor	0	9	7	18
Chain A, farnesyl pyrophosphate synthase	0	1	0	1
Geranylgeranyl pyrophosphate synthase	0	1	0	1
Farnesyl pyrophosphate synthase	0	2	0	2
Acetylcholinesterase	0	25	1	27
Hypoxanthine-guanine phosphoribosyltransferase	0	1	0	1
Farnesyl pyrophosphate synthase	0	1	0	1
Farnesyl pyrophosphate synthase	0	1	0	1
Fumarate hydratase	31	0	0	31
polyprotein	31	0	0	31
Pepsin A	0	1	0	1
Renin-1	0	1	0	1
Renin	0	1	0	1
Cathepsin D	0	1	0	1
Renin	0	1	0	1
Protease	0	3	1	4
Chain A, Ferritin light chain	36	0	0	36
Chain A, Cruzipain	25	0	0	25
retinoic acid receptor alpha isoform 1	0	2	0	2
retinoic acid receptor RXR-alpha isoform a	0	2	0	2
Retinoic acid receptor alpha	0	4	4	12
Retinoic acid receptor beta	0	4	4	12
Retinoic acid receptor alpha	0	3	3	6
Retinoic acid receptor gamma	0	4	4	12
Retinoic acid receptor gamma	0	2	3	5
Retinoic acid receptor RXR-alpha	0	5	8	15
Retinoic acid receptor beta	0	2	3	5
Nuclear receptor subfamily 4 group A member 1	0	0	1	1
Cellular retinoic acid-binding protein 2	0	0	3	3
Retinoic acid receptor RXR-alpha	0	3	4	7
Retinoic acid receptor RXR-beta	0	4	4	8
Retinoic acid receptor RXR-beta	0	2	4	6
Retinoic acid receptor RXR-gamma	0	2	4	6
Type-1 angiotensin II receptor	0	2	2	4
Cellular retinoic acid-binding protein 1	0	3	0	4
Retinoic acid receptor RXR-gamma	0	4	4	8
Type-2 angiotensin II receptor	0	4	1	5
Oxysterols receptor LXR-beta	0	0	1	1
Cellular retinoic acid-binding protein 1	0	0	3	3
Retinoic acid receptor RXR-alpha	0	0	1	1
Oxysterols receptor LXR-alpha	0	0	1	1
transcriptional regulator ERG isoform 3	12	0	0	12
ras-related protein Rab-9A	17	0	0	17
Polyphenol oxidase 2	0	8	0	13
Hypoxanthine-guanine phosphoribosyltransferase	0	0	0	4
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase	0	2	0	2
Xanthine dehydrogenase/oxidase	0	9	0	10
Nuclear receptor ROR-gamma	0	2	0	2
Xanthine dehydrogenase/oxidase	0	8	1	11
Purine nucleoside phosphorylase	0	0	2	2
TAR DNA-binding protein 43	22	0	0	22
Shiga toxin subunit A	0	2	0	2
Histamine H3 receptor	0	2	0	3
Glutamate receptor ionotropic, NMDA 2D	0	7	2	9
Glutamate receptor ionotropic, NMDA 3B	0	7	2	9
Integrin beta-3	25	3	1	29
Integrin alpha-IIb	25	3	1	29
Glutamate receptor 1	1	5	4	10
Glutamate receptor 3	1	5	4	10
Glutamate receptor 4	1	5	4	10
Glutamate receptor ionotropic, kainate 1	0	5	1	6
Glutamate receptor 1	0	1	1	2
Glutamate receptor 2	0	1	0	1
Glutamate receptor ionotropic, NMDA 1	0	23	4	32
Glutamate receptor ionotropic, kainate 1	0	3	1	4
Glutamate receptor ionotropic, kainate 2	0	5	1	6
Glutamate receptor 1	0	4	2	6
Glutamate receptor 2	0	4	2	6
Glutamate receptor 3	0	3	1	4
Glutamate receptor ionotropic, kainate 3	0	4	0	4
Excitatory amino acid transporter 1	0	3	0	4
Excitatory amino acid transporter 2	0	3	0	4
Excitatory amino acid transporter 3	0	3	0	4
Glutamate receptor 4	0	4	1	5
Glutamate receptor ionotropic, NMDA 2A	0	22	4	31
Glutamate receptor ionotropic, NMDA 2C	0	23	4	33
Glutamate receptor ionotropic, kainate 4	0	4	0	4
Glutamate receptor ionotropic, NMDA 1	0	10	2	12
Glutamate receptor ionotropic, NMDA 2A	0	10	2	12
Glutamate receptor ionotropic, kainate 2	0	3	1	4
Glutamate receptor ionotropic, kainate 3	0	2	0	2
Glutamate receptor ionotropic, NMDA 2B	0	10	2	12
Glutamate receptor ionotropic, NMDA 2C	0	7	2	9
Glutamate receptor ionotropic, kainate 4	0	1	0	1
Glutamate receptor ionotropic, kainate 5	0	2	0	2
Glutamate receptor ionotropic, NMDA 2D	0	22	4	31
Glutamate receptor ionotropic, kainate 5	0	4	0	4
Glutamate receptor ionotropic, NMDA 3A	0	7	2	9
Glutamate receptor ionotropic, NMDA 3B	0	22	4	31
Glutamate receptor ionotropic, NMDA 3A	0	22	4	31
Glutamate receptor 4	0	1	0	1
Glutamate receptor 3	0	1	0	1
Botulinum neurotoxin type A	0	1	0	1
Nitric oxide synthase, endothelial	0	3	0	3
Nitric oxide synthase, brain	0	3	1	5
Nitric oxide synthase, brain	0	3	0	4
Nitric oxide synthase, inducible	0	3	1	6
Tyrosine-protein kinase	0	0	1	1
cytochrome P450 2D6 isoform 1	45	0	0	45
cytochrome P450 2C19 precursor	40	0	0	40
cytochrome P450 2C9 precursor	36	0	0	36
neuropeptide S receptor isoform A	23	0	0	23
Cannabinoid receptor 1	0	17	6	30
Cannabinoid receptor 2	0	14	3	23
Histamine H2 receptor	52	6	1	63
Proteasome subunit beta type-11	0	0	1	2
thioredoxin glutathione reductase	15	0	0	15
lysosomal alpha-glucosidase preproprotein	12	0	0	12
cellular tumor antigen p53 isoform a	28	0	0	28
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1	31	0	0	31
eyes absent homolog 2 isoform a	4	0	0	4
streptokinase A precursor	0	0	6	6
Proteasome subunit alpha type-7	0	0	1	2
Transient receptor potential cation channel subfamily V member 1	0	4	2	6
Estrogen receptor	0	1	4	6
Fatty acid-binding protein, liver	0	5	0	5
Proteasome subunit beta type-1	0	0	1	2
Cruzipain	0	3	0	3
Proteasome subunit alpha type-1	0	0	1	2
Proteasome subunit alpha type-2	0	0	1	2
Proteasome subunit alpha type-3	0	0	1	2
Proteasome subunit alpha type-4	0	0	1	2
Proteasome subunit beta type-8	0	0	1	2
Proteasome subunit beta type-9	0	0	1	2
Proteasome subunit alpha type-5	0	0	1	2
Proteasome subunit beta type-4	0	0	1	2
Proteasome subunit beta type-6	0	0	1	2
Proteasome subunit beta type-5	0	3	1	5
Proteasome subunit beta type-10	0	0	1	2
Proteasome subunit beta type-3	0	0	1	2
Proteasome subunit beta type-2	0	0	1	2
Proteasome subunit alpha type-6	0	0	3	4
Estrogen receptor beta	0	1	4	6
Transient receptor potential cation channel subfamily V member 1	0	3	4	9
Proteasome subunit alpha-type 8	0	0	1	2
Proteasome subunit beta type-7	0	0	1	2
NEDD8-activating enzyme E1 regulatory subunit isoform a	0	1	0	1
NEDD8-conjugating enzyme Ubc12	0	1	0	1
histone acetyltransferase KAT2A isoform 1	34	0	0	34
Voltage-dependent L-type calcium channel subunit alpha-1C	0	8	0	8
Potassium channel subfamily K member 2	0	8	6	14
ATP-dependent translocase ABCB1	0	44	3	60
Alpha-2A adrenergic receptor	0	62	4	68
Alpha-2C adrenergic receptor	0	48	3	53
Voltage-dependent L-type calcium channel subunit alpha-1C	0	7	0	7
Spike glycoprotein	69	4	7	80
Sodium-dependent dopamine transporter	0	60	5	65
Voltage-dependent L-type calcium channel subunit alpha-1C	0	21	0	22
Potassium channel subfamily K member 2	0	3	0	3
Solute carrier family 22 member 3	0	3	0	3
Phenylethanolamine N-methyltransferase	0	5	0	6
Substance-P receptor	0	1	0	1
Cytochrome P450 2A5	0	3	0	3
Sigma non-opioid intracellular receptor 1	0	15	4	19
67.9K protein	34	0	0	34
phospholipase A2 precursor	0	1	0	1
cysteine protease ATG4B isoform a	0	1	0	1
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	4	0	0	4
Fatty-acid amide hydrolase 1	0	4	0	4
Fatty-acid amide hydrolase 1	0	1	0	2
Potassium channel subfamily K member 3	0	1	0	1
Polyunsaturated fatty acid lipoxygenase ALOX15B	26	1	0	27
Cannabinoid receptor 1	0	5	1	6
Cannabinoid receptor 2	0	2	3	5
Corticotropin-releasing factor receptor 2	0	2	0	2
Lanosterol 14-alpha demethylase	0	6	0	6
Cannabinoid receptor 2	0	3	0	3
Transient receptor potential cation channel subfamily V member 2	0	3	2	5
glucocerebrosidase	22	0	0	22
Atrial natriuretic peptide receptor 3	0	2	0	2
Type-1A angiotensin II receptor	0	4	2	6
Type-1 angiotensin II receptor	0	0	1	1
Type-1B angiotensin II receptor	0	4	0	4
Type-1 angiotensin II receptor	0	6	4	12
Type-2 angiotensin II receptor	0	4	0	4
Nicotinate phosphoribosyltransferase	0	4	0	4
Chain A, Putative fructose-1,6-bisphosphate aldolase	23	0	0	23
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, Transthyretin	0	0	1	1
Chain A, Transthyretin	0	0	1	1
Chain A, Transthyretin	0	0	1	1
Chain A, Transthyretin	0	0	1	1
Chain B, Transthyretin	0	0	1	1
Chain A, Transthyretin	0	0	1	1
Chain B, Transthyretin	0	0	1	1
Chain A, Casein kinase II subunit alpha	0	1	0	1
Chain A, Casein kinase II subunit alpha	0	1	0	1
Chain A, Casein Kinase Ii Subunit Alpha	0	1	0	1
endonuclease IV	17	0	0	17
RGS12	2	0	0	2
PPM1D protein	23	0	0	23
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	31	0	0	31
Neuraminidase	0	5	0	5
Parkin	15	0	0	15
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	14	0	0	14
Replicase polyprotein 1ab	0	6	7	13
NPC intracellular cholesterol transporter 1 precursor	12	0	0	12
peripheral myelin protein 22 isoform 1	33	0	0	33
hemoglobin subunit beta	6	0	0	6
parathyroid hormone/parathyroid hormone-related peptide receptor precursor	13	0	0	13
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1	2	0	0	2
ubiquitin carboxyl-terminal hydrolase 2 isoform a	14	0	0	14
M-phase phosphoprotein 8	32	0	0	32
Gamma-aminobutyric acid receptor subunit pi	0	12	0	12
Gamma-aminobutyric acid receptor subunit delta	0	12	0	12
Aldo-keto reductase family 1 member B10	0	2	0	2
G2/mitotic-specific cyclin-B2	0	3	0	3
Poly [ADP-ribose] polymerase tankyrase-1	0	1	0	1
Lysozyme C-1	0	1	0	1
Cationic trypsin	0	3	0	3
Estrogen receptor	1	18	5	26
Glucocorticoid receptor	1	18	7	34
Amyloid-beta precursor protein	2	12	0	15
Myeloperoxidase	0	10	0	10
Cyclin-dependent kinase 1	0	3	3	6
Beta-glucuronidase	0	2	0	2
Aldo-keto reductase family 1 member B1	0	49	0	49
Seed linoleate 13S-lipoxygenase-1	0	5	0	9
Neutrophil elastase	0	6	0	6
Poly [ADP-ribose] polymerase 1	0	1	0	1
Replicase polyprotein 1a	0	5	7	12
Replicase polyprotein 1ab	0	5	7	12
Replicase polyprotein 1ab	0	13	8	21
Replicase polyprotein 1ab	0	14	8	22
Androgen receptor	1	10	5	17
Sialidase	0	2	0	2
Serine/threonine-protein kinase pim-1	0	4	4	9
Aromatase	0	8	0	8
Angiotensin-converting enzyme	0	25	0	25
Cystic fibrosis transmembrane conductance regulator	0	2	2	4
17-beta-hydroxysteroid dehydrogenase type 1	0	3	0	4
Pyruvate kinase PKM	0	1	0	1
G2/mitotic-specific cyclin-B1	0	3	0	3
Gamma-aminobutyric acid receptor subunit alpha-1	0	13	3	16
Urease subunit alpha	0	4	0	4
Aldo-keto reductase family 1 member B1	0	7	0	7
G2/mitotic-specific cyclin-B	0	2	0	2
Mucin-1	0	1	0	1
Glycogen synthase kinase-3 beta	0	3	0	3
Gamma-aminobutyric acid receptor subunit beta-1	0	13	1	14
Gamma-aminobutyric acid receptor subunit gamma-2	0	13	3	16
Casein kinase II subunit alpha'	0	4	3	7
Amine oxidase [flavin-containing] A	0	24	0	24
Amine oxidase [flavin-containing] B	0	23	3	26
Gamma-aminobutyric acid receptor subunit beta-3	0	13	2	15
Substance-P receptor	0	7	0	7
Gamma-aminobutyric acid receptor subunit alpha-5	0	13	3	16
Multidrug resistance-associated protein 1	0	4	0	6
Gamma-aminobutyric acid receptor subunit alpha-3	0	13	3	16
Mu-type opioid receptor	0	34	9	49
Receptor-type tyrosine-protein kinase FLT3	0	3	3	6
Testosterone 17-beta-dehydrogenase 3	0	1	0	1
17-beta-hydroxysteroid dehydrogenase type 2	0	3	0	3
Acetylcholinesterase	0	3	0	3
Peroxisome proliferator-activated receptor gamma	0	1	5	6
Delta-type opioid receptor	0	24	5	35
Kappa-type opioid receptor	0	30	5	42
Homeobox protein Nkx-2.5	0	1	0	1
Tyrosine-protein kinase SYK	0	3	5	8
Gamma-aminobutyric acid receptor subunit alpha-2	0	13	2	15
Gamma-aminobutyric acid receptor subunit beta-2	0	13	2	15
Gamma-aminobutyric acid receptor subunit alpha-4	0	13	1	14
Glycogen synthase kinase-3 alpha	0	3	3	6
Glycogen synthase kinase-3 beta	0	5	3	8
Estrogen receptor	0	0	1	1
Death-associated protein kinase 1	0	2	2	4
Mitogen-activated protein kinase 10	0	2	3	5
Beta-secretase 1	0	6	0	7
Casein kinase II subunit beta	0	4	0	4
Casein kinase II subunit alpha	0	5	2	7
Urease subunit beta	0	4	0	4
Gamma-aminobutyric acid receptor subunit epsilon	0	12	0	12
Disintegrin and metalloproteinase domain-containing protein 17	12	0	0	12
Lactoperoxidase	0	4	0	4
MO15-related protein kinase Pfmrk	0	2	0	2
Inositol monophosphatase 1	26	0	0	26
Cyclin-dependent kinase 6	0	2	3	5
Cyclin-dependent-like kinase 5	0	4	3	7
Cyclin homolog	0	2	0	2
Transcription factor GATA-4	0	1	0	1
Cyclin-dependent kinase 5 activator 1	0	3	0	3
Gamma-aminobutyric acid receptor subunit alpha-6	0	13	1	14
Cytochrome P450 1B1	0	11	1	12
Substance-K receptor	0	3	0	3
Reverse transcriptase/RNaseH	0	2	3	9
Integrase	0	4	0	4
Gamma-aminobutyric acid receptor subunit gamma-1	0	12	0	12
Casein kinase II subunit alpha 3	0	3	0	3
Inositol polyphosphate multikinase	0	2	0	2
G2/mitotic-specific cyclin-B3	0	3	0	3
Estrogen receptor beta	1	12	5	19
Enoyl-acyl-carrier protein reductase	0	3	0	3
Aurora kinase B	0	2	3	5
NACHT, LRR and PYD domains-containing protein 3	0	3	0	3
Gamma-aminobutyric acid receptor subunit gamma-3	0	12	0	12
Myocilin	0	0	1	1
Cyclin-dependent kinase 1	0	2	0	2
Prenyltransferase homolog	0	0	0	1
Poly [ADP-ribose] polymerase tankyrase-2	0	2	0	2
MAP kinase-interacting serine/threonine-protein kinase 2	0	1	2	3
Carboxylic ester hydrolase	0	2	0	2
NADPH oxidase 4	0	2	0	2
Dipeptidyl peptidase 3	0	2	0	2
Estrogen receptor beta	0	0	1	1
Inositol hexakisphosphate kinase 2	0	2	0	2
Short transient receptor potential channel 5	0	2	0	2
Gamma-aminobutyric acid receptor subunit theta	0	12	0	12
Broad substrate specificity ATP-binding cassette transporter ABCG2	0	19	1	22
Sialidase-2	0	3	0	3
2,3-bisphosphoglycerate-independent phosphoglycerate mutase	2	0	0	2
potassium voltage-gated channel subfamily H member 2 isoform d	47	0	0	47
Solute carrier family 22 member 1	0	35	0	39
Tryptophan 5-hydroxylase 1	0	3	0	3
D(1A) dopamine receptor	0	46	5	56
D(4) dopamine receptor	0	33	5	44
D(1B) dopamine receptor	0	13	1	18
D(1B) dopamine receptor	0	15	0	15
5-hydroxytryptamine receptor 2A	0	61	8	73
D(4) dopamine receptor	0	17	1	18
D(3) dopamine receptor	0	63	10	83
E3 ubiquitin-protein ligase Mdm2	0	1	0	1
D	0	8	0	8
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
alpha-galactosidase	10	0	0	10
Nitric oxide synthase, endothelial	0	1	0	3
Nitric oxide synthase, inducible	0	4	0	5
Cationic amino acid transporter 3	0	1	0	1
5-hydroxytryptamine receptor 3E	0	7	2	10
Solute carrier family 22 member 2	0	16	0	21
5-hydroxytryptamine receptor 3A	0	2	2	4
5-hydroxytryptamine receptor 3B	0	7	2	10
Muscarinic acetylcholine receptor M3	0	44	5	52
Histamine H1 receptor	0	5	2	8
Histamine H1 receptor	0	34	4	41
5-hydroxytryptamine receptor 2B	0	69	5	74
5-hydroxytryptamine receptor 3A	0	11	2	14
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	8	0	8
Potassium voltage-gated channel subfamily H member 2	0	67	0	68
5-hydroxytryptamine receptor 3D	0	7	2	10
Multidrug and toxin extrusion protein 2	0	11	0	11
5-hydroxytryptamine receptor 3C	0	7	2	10
Multidrug and toxin extrusion protein 1	0	22	0	22
Histamine H3 receptor	0	9	0	9
Chain A, Hyaluronidase, phage associated	0	1	0	1
lethal(3)malignant brain tumor-like protein 1 isoform I	4	0	0	4
Pancreatic alpha-amylase	0	2	0	2
Albumin	0	1	0	1
Urease	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	0	0	1
Tyrosinase	0	4	0	4
Alpha-2B adrenergic receptor	0	64	3	69
Hyaluronate lyase	0	1	0	1
Prolyl hydroxylase EGLN2	0	1	0	2
Egl nine homolog 1	0	2	1	4
Prolyl hydroxylase EGLN3	0	0	0	1
Hypoxia-inducible factor 1-alpha inhibitor	0	3	0	4
Solute carrier family 23 member 1	0	1	0	1
Chain A, Phospholipase A2 isoform 3	0	0	1	1
GTP-binding protein (rab7)	0	0	3	3
ras protein, partial	0	0	3	3
hypothetical protein, conserved	5	0	0	5
Rac1 protein	0	0	3	3
cell division cycle 42 (GTP binding protein, 25kDa), partial	0	0	3	3
Prostaglandin-H2 D-isomerase	0	2	0	2
Prostaglandin G/H synthase 1	0	5	0	6
Prostaglandin G/H synthase 2	0	4	0	5
Fatty acid-binding protein, liver	0	5	1	6
Glutathione hydrolase 1 proenzyme	0	1	0	1
Urotensin-2 receptor	0	2	0	2
4-aminobutyrate aminotransferase, mitochondrial	0	2	0	2
Ras-related protein Rab-2A	0	0	3	3
Prostaglandin G/H synthase 2	0	8	0	8
Rho-associated protein kinase 2	0	2	0	2
Solute carrier family 22 member 20	0	4	0	4
Solute carrier family 22 member 6	0	4	0	4
Sodium-dependent noradrenaline transporter	0	70	6	76
Solute carrier organic anion transporter family member 2B1	0	4	0	8
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	6	0	6
Insulin receptor	0	4	0	4
Dipeptidyl peptidase 4	0	1	0	1
Solute carrier organic anion transporter family member 1B3	0	13	0	18
Solute carrier organic anion transporter family member 1B1	0	19	0	25
Amine oxidase [flavin-containing] A	0	9	1	11
Small conductance calcium-activated potassium channel protein 3	0	2	1	3
Atrial natriuretic peptide receptor 1	0	1	1	2
Atrial natriuretic peptide receptor 1	0	0	1	1
cystic fibrosis transmembrane conductance regulator	0	1	0	1
DNA polymerase beta	9	0	0	9
short transient receptor potential channel 6 isoform 1	0	0	3	3
5-hydroxytryptamine receptor 4	0	52	2	54
Muscarinic acetylcholine receptor M2	0	44	6	55
Muscarinic acetylcholine receptor M4	0	40	3	46
Muscarinic acetylcholine receptor M1	0	19	5	27
Muscarinic acetylcholine receptor M3	0	17	5	25
Muscarinic acetylcholine receptor M4	0	17	5	25
Muscarinic acetylcholine receptor M5	0	16	5	24
Muscarinic acetylcholine receptor M5	0	39	2	44
Muscarinic acetylcholine receptor M2	0	19	6	29
Muscarinic acetylcholine receptor M1	0	45	8	59
Muscarinic acetylcholine receptor M1	0	1	2	5
Muscarinic acetylcholine receptor M4	0	4	1	6
Muscarinic acetylcholine receptor	0	2	2	5
P53	1	0	0	1
Protein-arginine deiminase type-4	0	4	0	4
Gamma-aminobutyric acid type B receptor subunit 2	0	3	2	5
Gamma-aminobutyric acid type B receptor subunit 2	0	3	0	3
Gamma-aminobutyric acid type B receptor subunit 1	0	3	2	5
Gamma-aminobutyric acid type B receptor subunit 1	0	2	0	2
Chain A, Integrase	0	1	0	1
Chain A, Integrase	0	1	0	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, GCN4P1	0	0	1	1
Chain B, GCN4P1	0	0	1	1
Chain C, GCN4P1	0	0	1	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, Replicase polyprotein 1ab	0	1	0	1
Chain A, 3C-like proteinase	0	1	0	1
Endolysin	0	0	1	1
DNA dC->dU-editing enzyme APOBEC-3F isoform a	4	0	0	4
Aryl hydrocarbon receptor	0	0	1	1
beta-2 adrenergic receptor	8	0	2	10
core protein, partial	0	1	0	1
Peroxisome proliferator-activated receptor alpha	0	1	3	4
Peroxisome proliferator-activated receptor delta	0	0	1	1
Peroxisome proliferator-activated receptor gamma	0	5	12	18
Peroxisome proliferator-activated receptor delta	0	0	2	2
Peroxisome proliferator-activated receptor alpha	0	2	5	7
caspase-1 isoform alpha precursor	7	0	0	7
Caspase-7	8	0	0	8
Nuclear receptor subfamily 1 group I member 2	0	0	8	8
Endothelin receptor type B	0	2	0	2
Endothelin receptor type B	0	4	1	5
Endothelin-1 receptor	0	5	1	6
Endothelin-1 receptor	0	2	1	3
Endothelin receptor type B	0	0	1	1
Deoxyhypusine synthase	0	1	0	1
Sodium/bile acid cotransporter	0	3	1	4
Endothelin-1 receptor	0	1	0	1
serine/threonine-protein kinase mTOR isoform 1	28	0	0	28
D(3) dopamine receptor	0	2	1	3
Angiotensin-converting enzyme	0	4	0	5
B2 bradykinin receptor	0	1	0	1
B2 bradykinin receptor	0	4	1	7
B1 bradykinin receptor	0	1	0	1
Olfactory receptor 51E2	0	1	3	4
Genome polyprotein	0	2	1	3
ATP-dependent translocase ABCB1	0	12	0	12
ATP-dependent translocase ABCB1	0	12	1	13
Alpha-synuclein	12	8	1	21
Integrin alpha-5	0	1	0	1
UDP-glucuronosyltransferase 2B7	0	5	0	12
UDP-glucuronosyltransferase 2B10	0	3	0	3
Beta-2 adrenergic receptor	0	8	0	9
Beta-1 adrenergic receptor	0	10	2	13
Beta-3 adrenergic receptor	0	6	0	6
Alpha-2A adrenergic receptor	0	3	0	3
Chain A, Glycogen Phosphorylase	0	1	0	1
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Chitinase	0	1	0	1
atrial natriuretic peptide receptor 1 precursor	5	0	0	5
Cholinesterase	0	12	0	12
Glycogen phosphorylase, liver form	0	1	0	1
Glycogen phosphorylase, muscle form	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	12	0	12
Vasopressin V2 receptor	0	0	0	2
Serine/threonine-protein kinase mTOR	0	4	3	7
Adenosine receptor A2a	0	2	0	2
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	3	2	5
DNA-dependent protein kinase catalytic subunit	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	2	0	2
Adenylate cyclase type 1	0	0	0	2
Chitotriosidase-1	0	4	1	5
Serine-protein kinase ATM	0	1	0	1
Serine/threonine-protein kinase ATR	0	1	1	2
Adenosine receptor A2b	0	1	0	3
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	2	0	2
Palmitoleoyl-protein carboxylesterase NOTUM	0	2	3	5
Endochitinase B1	0	4	1	5
Phosphodiesterase	0	2	0	2
Guanine deaminase	0	2	0	3
Chain A, Vitamin D Nuclear Receptor	0	0	1	1
Vitamin D3 receptor	0	0	1	1
Vitamin D-binding protein	0	0	1	1
Vitamin D3 receptor	0	1	2	4
Vitamin D3 receptor	0	1	1	3
Vitamin D3 receptor	0	0	1	1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	0	0	1	1
Vitamin D3 receptor	0	1	1	2
Transporter	0	7	0	7
Vitamin D3 receptor A	0	0	2	2
Acetylcholinesterase	0	13	0	13
Cytochrome P450 2C11	0	2	0	2
Steroid 17-alpha-hydroxylase/17,20 lyase	0	2	0	2
Cytochrome P450 3A5	0	2	0	2
Cytochrome P450 3A7	0	1	0	1
Caspase-1	0	2	1	4
N-acylethanolamine-hydrolyzing acid amidase	0	1	0	1
Heat sensitive channel TRPV3	0	1	1	2
Sigma intracellular receptor 2	0	5	0	5
Transient receptor potential cation channel subfamily M member 8	0	1	1	2
Transient receptor potential cation channel subfamily V member 4	0	2	2	4
G-protein coupled receptor 55	0	1	3	4
Diacylglycerol lipase-alpha	0	1	0	1
transient receptor potential cation channel subfamily V member 1	4	0	0	4
Lysine-specific histone demethylase 1A	0	4	0	4
NADH-ubiquinone oxidoreductase chain 1	0	1	0	1
Potassium voltage-gated channel subfamily A member 1	0	2	0	2
Chain A, serum paraoxonase	0	1	0	1
histone-lysine N-methyltransferase 2A isoform 2 precursor	15	0	0	15
Toll-like receptor 4	0	2	0	2
Potassium channel subfamily K member 10	0	1	0	1
Nuclear receptor subfamily 3 group C member 3	0	23	0	23
Chain A, Carbonic anhydrase II	0	1	0	1
interferon gamma precursor	0	0	0	4
prostaglandin E2 receptor EP2 subtype	1	0	0	2
Prostaglandin E synthase	0	3	0	3
3-phosphoinositide-dependent protein kinase 1	0	1	2	3
cGMP-specific 3',5'-cyclic phosphodiesterase	0	7	0	7
Cytochrome c oxidase subunit 1	0	1	0	1
Cytochrome c oxidase subunit 2	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Cytochrome c oxidase subunit 2	0	2	0	2
Procathepsin L	0	6	7	13
Quinolone resistance protein NorA	0	3	0	4
Calpain-2 catalytic subunit	0	1	0	1
Prostaglandin G/H synthase 1	0	2	0	2
Sodium/hydrogen exchanger 1	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	5	0	5
Bifunctional epoxide hydrolase 2	0	3	0	3
Prostaglandin G/H synthase 2	0	3	0	3
Prostaglandin G/H synthase 2	0	2	0	3
Prostaglandin G/H synthase 1	0	3	0	3
Prostaglandin G/H synthase 1	0	1	0	1
Cyclooxygenase-2	0	1	0	1
Rap guanine nucleotide exchange factor 4	9	0	0	9
P2Y purinoceptor 12	0	2	0	2
atrial natriuretic peptide receptor 2 precursor	15	0	0	15
Angiopoietin-1 receptor	0	0	3	3
Histamine H4 receptor	0	6	2	8
Caspase-2	0	0	1	1
Chain A, BCL-2-RELATED PROTEIN A1	0	0	3	3
PAX8	0	0	0	3
PINK1	5	0	0	5
heat shock protein 90	0	0	2	2
calcineurin A1, putative	0	0	2	2
hepatocyte nuclear factor 4-alpha isoform 2	0	2	0	2
perilipin-5	0	5	0	5
perilipin-1	0	5	0	5
huntingtin isoform 2	11	0	0	11
ubiquitin-conjugating enzyme E2 N	0	3	0	3
nuclear factor NF-kappa-B p105 subunit isoform 1	4	0	0	4
protein AF-9 isoform a	0	0	0	2
melanocortin receptor 4	0	1	0	1
CAAX prenyl protease	0	0	0	1
bcl-2-related protein A1	0	2	0	2
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a	0	5	0	5
glycogen synthase kinase-3 alpha	0	0	0	1
hexokinase HKDC1	0	1	0	1
DNA repair protein RAD52 homolog isoform a	0	0	0	1
bcl-2-like protein 11 isoform 1	0	0	3	3
Synaptojanin-2	0	1	0	1
Synaptojanin-1	0	1	0	1
Solute carrier family 22 member 3	0	10	0	10
Glutathione reductase, mitochondrial	0	6	0	7
72 kDa type IV collagenase	0	3	0	3
Matrix metalloproteinase-9	0	5	0	5
Trypanothione reductase	0	7	0	7
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	0	1	0	1
Spermine oxidase	0	1	0	1
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase	0	2	0	2
Spike glycoprotein	0	4	7	11
glucose-6-phosphate 1-dehydrogenase isoform b	0	2	0	2
Transmembrane protease serine 2	0	4	7	11
Dihydrofolate reductase	0	3	0	3
DNA ligase	0	1	0	1
Riboflavin-binding protein	0	0	1	1
Major prion protein	0	0	4	4
Histidine-rich protein PFHRP-II	0	3	0	4
Spike glycoprotein	0	1	0	1
Ribosyldihydronicotinamide dehydrogenase [quinone]	0	5	3	8
DNA ligase 1	0	1	0	1
Nuclear receptor subfamily 4 group A member 2	0	0	2	2
Calcium-dependent protein kinase 1	0	0	1	1
DNA ligase A	0	1	0	1
Phosphoethanolamine N-methyltransferase	0	1	0	1
Angiotensin-converting enzyme 2	0	4	7	11
Cysteine proteinase falcipain 2a	0	1	0	1
Cysteine proteinase falcipain 2a	0	1	0	1
NADPH oxidase 1	0	2	0	2
Snq2p	0	0	0	3
Adenylate cyclase type 1	0	4	0	4
Voltage-dependent L-type calcium channel subunit alpha-1F	0	16	0	16
Albumin	0	5	10	17
Albumin	0	0	7	7
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	7	0	7
Major prion protein	0	0	1	1
Cys-loop ligand-gated ion channel	0	1	0	1
Calmodulin-1	0	4	1	5
Sphingomyelin phosphodiesterase	0	2	0	2
Substance-K receptor	0	14	0	14
Adenylate cyclase type 3	0	4	0	4
Histamine H2 receptor	0	28	2	30
Adenylate cyclase type 2	0	4	0	4
Adenylate cyclase type 4	0	4	0	4
Melanocortin receptor 4	0	4	0	4
Melanocortin receptor 5	0	8	0	8
Pleiotropic ABC efflux transporter of multiple drugs	0	3	0	6
Sodium channel protein type 1 subunit alpha	0	5	0	5
Sodium channel protein type 4 subunit alpha	0	7	0	9
Adenylate cyclase type 8	0	4	0	4
Melanocortin receptor 3	0	4	0	4
Gastrin/cholecystokinin type B receptor	0	3	0	3
Calmodulin	0	1	2	3
Aldehyde oxidase 1	0	1	0	1
Sodium channel protein type 7 subunit alpha	0	4	0	4
Voltage-dependent L-type calcium channel subunit alpha-1D	0	16	0	16
Adenylate cyclase type 6	0	4	0	4
Adenylate cyclase type 5	0	4	0	4
Aldehyde oxidase	0	4	0	4
Voltage-dependent L-type calcium channel subunit alpha-1S	0	16	0	16
Sodium channel protein type 5 subunit alpha	0	11	0	11
Sodium channel protein type 9 subunit alpha	0	6	0	6
Adenylyl cyclase 7	0	4	0	4
Sodium channel protein type 2 subunit alpha	0	6	0	6
Sodium channel protein type 3 subunit alpha	0	6	0	6
Sodium channel protein type 11 subunit alpha	0	4	0	4
Sodium channel protein type 8 subunit alpha	0	4	0	4
Sodium channel protein type 10 subunit alpha	0	5	0	5
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7	0	0	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	2
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	2	0	2
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	2	0	2
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	6	0	6
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	4	0	4
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	2	0	3
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	2	0	3
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	3
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	2	0	3
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	4	0	4
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	5	0	5
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	12	0	12
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	8	0	8
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	12	0	12
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	0	6	0	6
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	6	0	6
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	0	7	0	7
Phosphodiesterase	0	2	0	2
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	0	3	0	3
cAMP-specific 3',5'-cyclic phosphodiesterase 7B	0	3	0	3
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	3	0	3
Solute carrier family 22 member 1	0	2	0	2
Solute carrier family 22 member 2	0	2	0	2
Potassium-transporting ATPase alpha chain 1	0	1	0	1
Potassium-transporting ATPase subunit beta	0	1	0	1
Solute carrier family 22 member 6	0	6	0	11
Solute carrier family 22 member 1	0	11	0	14
Solute carrier family 22 member 8	0	7	0	13
Solute carrier family 22 member 11	0	2	0	8
Solute carrier family 22 member 2	0	8	0	9
Solute carrier family 22 member 4	0	1	0	1
Solute carrier family 22 member 8	0	3	0	5
DNA gyrase subunit B	0	1	0	1
DNA gyrase subunit A	0	1	0	1
DNA gyrase subunit B	0	1	0	2
DNA gyrase subunit A	0	1	0	3
DNA gyrase subunit B	0	1	0	3
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	2
DNA topoisomerase 4 subunit A	0	1	0	2
DNA topoisomerase 2-alpha	0	1	3	7
DNA gyrase subunit A	0	1	0	2
Multidrug resistance protein MdtK	0	0	1	1
DNA gyrase subunit B	0	1	0	1
DNA gyrase subunit A	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	0	0	1
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	1
Sodium-dependent noradrenaline transporter	0	4	0	4
Aldo-keto reductase family 1 member B1	0	6	0	6
Aromatase	0	1	0	1
Sodium-dependent serotonin transporter	0	4	0	4
Sodium-dependent dopamine transporter	0	6	0	6
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Beta-lactamase	0	1	0	1
3-dehydroquinate dehydratase	0	0	1	1
ATP-citrate synthase	0	1	0	2
Ribonuclease T	0	0	0	1
Cell death-related nuclease 4	0	0	0	1
3-dehydroquinate dehydratase	0	0	1	1
Prolyl 4-hydroxylase	0	4	0	4
Alpha-ketoglutarate-dependent dioxygenase FTO	0	3	0	3
tyrosine-protein kinase Yes	5	0	0	5
relaxin receptor 1 isoform 1	2	0	0	2
Deoxycytidine kinase	0	0	3	5
Histamine H1 receptor	0	9	0	9
Trypanothione reductase	0	1	0	1
Voltage-dependent N-type calcium channel subunit alpha-1B	0	4	0	4
Envelope glycoprotein	0	0	4	4
Gamma-aminobutyric acid receptor subunit alpha-1	0	3	0	4
Gamma-aminobutyric acid receptor subunit beta-1	0	3	0	4
Gamma-aminobutyric acid receptor subunit alpha-2	0	3	0	4
Gamma-aminobutyric acid receptor subunit alpha-3	0	3	0	4
Gamma-aminobutyric acid receptor subunit alpha-4	0	3	0	4
Gamma-aminobutyric acid receptor subunit gamma-2	0	3	0	4
Translocator protein	0	1	0	1
Translocator protein	0	4	0	4
Cholecystokinin receptor type A	0	2	0	2
Gastrin/cholecystokinin type B receptor	0	2	0	2
Beta-1 adrenergic receptor	0	2	5	8
Alpha-1B adrenergic receptor	0	0	1	1
Membrane primary amine oxidase	0	1	0	1
Alpha-1A adrenergic receptor	0	2	1	3
Alpha-2B adrenergic receptor	0	2	0	3
Alpha-2C adrenergic receptor	0	2	0	3
Alpha-2A adrenergic receptor	0	2	0	3
Nischarin	0	2	0	2
Nischarin	0	4	0	4
nonstructural protein 1	21	0	0	21
Liver carboxylesterase 1	0	1	0	4
P2Y purinoceptor 12	0	4	0	4
Sigma non-opioid intracellular receptor 1	0	1	0	1
Amine oxidase [flavin-containing] A	0	7	0	7
Amine oxidase [flavin-containing] B	0	9	0	9
Sigma intracellular receptor 2	0	1	0	1
isocitrate dehydrogenase 1, partial	3	0	0	3
nuclear receptor subfamily 1, group I, member 2	16	0	0	16
heat shock protein HSP 90-alpha isoform 2	0	2	0	5
Intermediate conductance calcium-activated potassium channel protein 4	0	1	0	1
Chymotrypsinogen A	0	4	0	4
Steroid 17-alpha-hydroxylase/17,20 lyase	0	2	0	2
Heme oxygenase 1	0	2	0	2
Epoxide hydrolase 1	0	0	0	1
Glycine receptor subunit alpha-1	0	18	0	18
Potassium-transporting ATPase subunit beta	0	1	0	1
Potassium-transporting ATPase alpha chain 1	0	1	0	1
Glycine receptor subunit beta	0	18	0	18
Potassium voltage-gated channel subfamily A member 3	0	2	0	2
Glycine receptor subunit alpha-2	0	18	0	18
Heme oxygenase 2	0	2	0	2
Glycine receptor subunit alpha-3	0	18	0	18
Thromboxane-A synthase	0	5	0	5
C-X-C chemokine receptor type 1	0	2	0	2
Substance-P receptor	0	5	0	5
Platelet-activating factor receptor	1	2	0	4
Vasopressin V2 receptor	0	3	1	4
Malate dehydrogenase, cytoplasmic	0	2	0	2
C-C chemokine receptor type 4	0	4	0	4
Transitional endoplasmic reticulum ATPase	0	1	0	1
Cytochrome P450 144	0	0	1	1
Steroid C26-monooxygenase	0	0	1	1
Cytochrome P450 130	0	0	1	1
Cytochrome P450 130	0	0	1	1
Steroid C26-monooxygenase	0	0	1	1
Mycocyclosin synthase	0	0	1	1
Lanosterol 14-alpha demethylase	0	0	1	1
Nuclear receptor subfamily 1 group I member 3	0	2	0	2
Sterol 14-alpha demethylase	0	0	1	1
Indoleamine 2,3-dioxygenase 2	0	3	0	3
Bile acid receptor	0	3	0	3
14-alpha sterol demethylase	0	0	1	1
Cysteinyl leukotriene receptor 1	0	2	0	2
HSP40, subfamily A [Plasmodium falciparum 3D7]	0	0	0	2
heat shock protein 90, putative	0	0	0	3
5-hydroxytryptamine receptor 3A	0	5	0	5
5-hydroxytryptamine receptor 2C	0	4	0	4
5-hydroxytryptamine receptor 2A	0	3	0	3
D(2) dopamine receptor	0	2	0	2
D(2) dopamine receptor	0	4	0	4
5-hydroxytryptamine receptor 2B	0	3	0	3
5-hydroxytryptamine receptor 4	0	3	1	4
Cholecystokinin receptor type A	0	2	0	2
5-hydroxytryptamine receptor 1A	0	2	0	2
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain H, Fab M82G2, Heavy chain	0	0	1	1
Chain L, Fab M82G2, Light chain	0	0	1	1
Chain H, Fab M82g2, Heavy Chain	0	0	1	1
Chain L, Fab M82g2, Light Chain	0	0	1	1
Fatty acid-binding protein, heart	0	1	0	1
Muscarinic acetylcholine receptor M2	0	1	0	1
Lysosomal Pro-X carboxypeptidase	0	2	0	2
Leukotriene B4 receptor 1	0	3	0	4
Leukotriene B4 receptor 2	0	2	0	3
nuclear receptor subfamily 0 group B member 1	0	1	0	1
steroidogenic factor 1	0	1	0	1
Tubulin alpha-1A chain	0	2	1	3
Tubulin beta chain	0	2	1	3
Plasma kallikrein	0	0	0	5
Tubulin beta-4A chain	0	3	2	6
Tubulin beta chain	0	3	2	6
Tubulin alpha-3C chain	0	3	2	6
Tubulin alpha-1B chain	0	3	2	6
Tubulin alpha-4A chain	0	3	2	6
Tubulin beta-4B chain	0	3	2	6
Vesicular acetylcholine transporter	0	1	0	1
Tubulin beta-3 chain	0	3	2	6
Tubulin beta-2A chain	0	3	2	6
Tubulin polymerization-promoting protein	0	0	1	1
Tubulin beta-8 chain	0	3	2	6
Tubulin beta-2B chain	0	2	0	2
Tubulin alpha-3E chain	0	3	2	6
Tubulin alpha-1A chain	0	3	2	6
Similar to alpha-tubulin isoform 1	0	1	0	1
Similar to alpha-tubulin isoform 1	0	1	0	1
CREB-binding protein	1	1	0	2
Tubulin alpha-1C chain	0	3	2	6
Tubulin beta-6 chain	0	3	2	6
Tubulin beta-2B chain	0	3	2	6
Tubulin beta-1 chain	0	3	2	6
Sex hormone-binding globulin	0	0	4	4
Corticosteroid-binding globulin	0	4	0	4
Mineralocorticoid receptor	1	8	4	15
C-8 sterol isomerase	0	4	0	4
Solute carrier organic anion transporter family member 1A1	0	3	0	5
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	5	1	6
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Proton-coupled amino acid transporter 1	0	8	0	8
Chain A, Breast cancer type 1 susceptibility protein	3	0	0	3
Nrf2	3	0	0	3
alkaline phosphatase, intestinal	0	1	0	1
toll-like receptor 9	0	1	0	1
TPA: protein transporter TIM10	0	1	0	1
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein	0	1	0	1
polyunsaturated fatty acid lipoxygenase ALOX12	6	0	0	6
intestinal alkaline phosphatase precursor	0	1	0	1
pyruvate kinase PKM isoform a	2	0	0	2
tumor susceptibility gene 101 protein	2	0	0	2
alkaline phosphatase, germ cell type preproprotein	0	1	0	1
hypothetical protein SA1422	0	1	0	1
D-amino-acid oxidase	0	1	0	1
Phospholipase A2	0	2	0	2
Neuronal proto-oncogene tyrosine-protein kinase Src	0	1	0	1
Glutathione S-transferase P	0	2	0	2
Microtubule-associated protein tau	0	1	0	2
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	1	0	1
Tissue factor	0	4	0	4
Aminopeptidase N	0	1	0	1
Aminopeptidase N	0	1	0	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	2	0	2
Voltage-dependent L-type calcium channel subunit alpha-1D	0	4	0	4
Voltage-dependent L-type calcium channel subunit alpha-1S	0	3	0	3
Lactoylglutathione lyase	0	5	0	5
Histone acetyltransferase p300	0	1	0	1
Serine/threonine-protein kinase PAK 1	0	1	2	3
Nuclear factor erythroid 2-related factor 2	0	1	3	6
Thioredoxin reductase 1, cytoplasmic	0	1	0	1
Thioredoxin reductase 3	0	1	0	1
Sortase A	0	1	0	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	0	2	0	2
Cysteine protease	0	1	0	1
Thioredoxin reductase 2, mitochondrial	0	1	0	1
CDGSH iron-sulfur domain-containing protein 1	0	10	0	10
Lymphocyte antigen 96	0	0	1	1
Beta lactamase (plasmid)	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
D-alanine--D-alanine ligase	0	1	0	1
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase	0	1	0	1
Acetylcholine receptor subunit beta	0	4	1	5
Acetylcholine receptor subunit gamma	0	4	1	5
Acetylcholine receptor subunit delta	0	4	2	6
Deoxycytidine kinase	0	0	0	1
Alpha-tocopherol transfer protein	0	0	1	1
Isocitrate lyase	0	1	0	1
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase	0	1	0	1
Dihydrofolate reductase	0	3	0	3
Beta-glucuronidase	0	2	0	2
Beta-glucuronidase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	6	0	6
G-protein coupled bile acid receptor 1	0	1	2	3
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
NPC1-like intracellular cholesterol transporter 1	0	1	1	2
Solute carrier organic anion transporter family member 1A4	0	2	0	6
Solute carrier organic anion transporter family member 1A5	0	0	0	3
Solute carrier organic anion transporter family member 1A2	0	0	0	2
Solute carrier organic anion transporter family member 1A3	0	3	0	7
ATP-binding cassette sub-family C member 11	0	0	0	2
Solute carrier organic anion transporter family member 1A1	0	0	0	1
Solute carrier organic anion transporter family member 1B2	0	1	0	3
Thymidine kinase, cytosolic	0	5	0	9
AAA family ATPase	0	0	0	1
Sterol O-acyltransferase 1	0	2	0	2
Trace amine-associated receptor 1	0	0	2	2
Trace amine-associated receptor 1	0	0	2	2
Trace amine-associated receptor 1	0	0	3	3
Trace amine-associated receptor 1	0	0	3	3
Sodium channel protein type 1 subunit alpha	0	5	0	5
Sodium channel protein type 2 subunit alpha	0	5	0	5
Sodium channel protein type 3 subunit alpha	0	3	0	3
Cytochrome P450 2D1	0	3	0	3
Cytochrome P450 2D26	0	3	0	3
Cytochrome P450 2D3	0	3	0	3
Taste receptor type 2 member 46	0	0	1	1
Cytochrome P450 2D4	0	3	0	3
STAT3, partial	0	1	0	1
tumor necrosis factor	2	0	0	2
signal transducer and activator of transcription 1-alpha/beta isoform alpha	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-1	0	2	0	2
Sodium/potassium-transporting ATPase subunit beta-1	0	2	0	2
Sodium/potassium-transporting ATPase subunit alpha-2	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-2	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-2	0	2	0	2
Sodium/potassium-transporting ATPase subunit alpha-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-3	0	1	0	1
Sodium/potassium-transporting ATPase subunit gamma	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-4	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-4	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	1	0	2
Solute carrier organic anion transporter family member 4C1	0	0	0	1
Solute carrier organic anion transporter family member 1A4	0	0	0	1
Neuronal acetylcholine receptor subunit alpha-5	0	1	2	3
Neuronal acetylcholine receptor subunit beta-4	0	3	0	3
Neuronal acetylcholine receptor subunit beta-2	0	3	1	4
runt-related transcription factor 1 isoform AML1b	2	0	0	2
core-binding factor subunit beta isoform 2	2	0	0	2
Thromboxane A2 receptor	0	2	1	4
Prostaglandin E2 receptor EP1 subtype	0	3	3	6
Prostaglandin E2 receptor EP4 subtype	0	3	1	4
Prostaglandin F2-alpha receptor	0	2	0	2
Prostaglandin F2-alpha receptor	0	2	2	4
Prostaglandin E2 receptor EP3 subtype	0	4	2	6
Prostaglandin E2 receptor EP2 subtype	0	3	2	5
Prostaglandin F2-alpha receptor	0	0	1	1
Prostacyclin receptor	0	5	2	7
Prostaglandin D2 receptor	0	1	1	2
Solute carrier family 22 member 7	0	3	0	8
Solute carrier organic anion transporter family member 2A1	0	1	0	4
Solute carrier organic anion transporter family member 2A1	0	1	0	1
Solute carrier organic anion transporter family member 2B1	0	1	0	1
Solute carrier family 22 member 7	0	1	0	5
Prostaglandin E2 receptor EP3 subtype	0	2	0	2
Prostaglandin E2 receptor EP4 subtype	0	2	0	2
Prostaglandin E2 receptor EP1 subtype	0	2	0	2
Prostaglandin E2 receptor EP4 subtype	0	1	1	2
Prostaglandin E2 receptor EP2 subtype	0	2	0	2
Prostaglandin E2 receptor EP2 subtype	0	1	1	2
Solute carrier family 22 member 7	0	0	0	1
90-kda heat shock protein beta HSP90 beta, partial	0	2	0	2
DNA polymerase III, partial	3	0	0	3
LANA	0	0	0	1
serine-protein kinase ATM isoform a	2	0	0	2
kelch-like ECH-associated protein 1	0	0	0	2
Multidrug resistance-associated protein 5	0	1	0	1
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	0	1	0	1
3',5'-cyclic-AMP phosphodiesterase	0	2	0	2
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	0	1	0	1
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	1	0	1
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	0	1	0	1
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	0	1	0	1
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	0	2	0	2
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	1	0	1
Exopolyphosphatase PRUNE1	0	1	0	1
Single-stranded DNA cytosine deaminase	3	0	0	3
Phosphodiesterase	0	1	0	1
LacZ protein (plasmid)	0	0	1	1
type-1 angiotensin II receptor	0	1	0	1
polypyrimidine tract-binding protein 1 isoform a	1	0	0	1
apelin receptor	0	1	0	1
Vpr	5	0	0	5
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase	0	1	0	1
Carbamate kinase	0	1	0	1
Retinal dehydrogenase 1	0	1	0	1
Aldehyde dehydrogenase, mitochondrial	0	1	0	1
C-X-C chemokine receptor type 2	0	2	0	2
Mitogen-activated protein kinase 3	0	1	3	4
Protein-lysine 6-oxidase	0	1	0	1
Lysine-specific demethylase 5A	0	2	0	2
C-C chemokine receptor type 2	0	4	0	4
C-C chemokine receptor type 5	0	2	0	2
Gasdermin-D	0	1	0	1
Lysyl oxidase homolog 3	0	1	0	1
NACHT, LRR and PYD domains-containing protein 3	0	2	0	2
Lysyl oxidase homolog 4	0	1	0	1
Histone-lysine N-methyltransferase EHMT2	0	1	0	1
Monoglyceride lipase	0	2	0	2
Gasdermin-D	0	1	0	1
Histone-lysine N-methyltransferase EHMT1	0	1	0	1
Lysyl oxidase homolog 2	0	1	0	1
hypothetical protein CAALFM_CR05890CA	0	0	0	1
H3 histone acetyltransferase	0	0	0	1
large T antigen	0	2	0	2
Kinesin-like protein KIF11	0	1	0	1
Nucleotide-binding oligomerization domain-containing protein 2	0	1	0	1
Glycine receptor subunit alpha-1	0	0	3	3
N-arachidonyl glycine receptor	0	1	1	2
Lysophosphatidylserine lipase ABHD12	0	1	0	1
Monoacylglycerol lipase ABHD6	0	1	0	1
replicative DNA helicase	0	0	0	1
recombinase A	0	0	1	1
UDP-glucuronosyltransferase 2B17	0	0	0	1
UDP-glucuronosyltransferase 1A7	0	0	0	1
Eyes absent homolog 2	0	1	0	1
Metallo-beta-lactamase VIM-13	0	1	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase VIM-1	0	1	0	1
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta))	0	1	0	1
Trypsin	0	1	0	1
Coagulation factor VII	0	2	0	2
Oxoeicosanoid receptor 1	0	1	0	1
chaperonin-containing TCP-1 beta subunit homolog	2	0	0	2
Serine/threonine-protein kinase B-raf	0	1	0	1
Motilin receptor	0	0	1	1
low molecular weight phosphotyrosine protein phosphatase isoform c	0	1	0	1
Motilin receptor	0	1	1	2
30S ribosomal protein S6	0	2	1	3
30S ribosomal protein S7	0	2	1	3
50S ribosomal protein L15	0	2	1	3
50S ribosomal protein L10	0	2	1	3
50S ribosomal protein L11	0	2	1	3
50S ribosomal protein L7/L12	0	2	1	3
50S ribosomal protein L19	0	2	1	3
50S ribosomal protein L1	0	2	1	3
50S ribosomal protein L20	0	2	1	3
50S ribosomal protein L27	0	2	1	3
50S ribosomal protein L28	0	2	1	3
50S ribosomal protein L29	0	2	1	3
50S ribosomal protein L31	0	2	1	3
50S ribosomal protein L31 type B	0	2	1	3
50S ribosomal protein L32	0	2	1	3
50S ribosomal protein L33	0	2	1	3
50S ribosomal protein L34	0	2	1	3
50S ribosomal protein L35	0	2	1	3
50S ribosomal protein L36	0	2	1	3
30S ribosomal protein S10	0	2	1	3
30S ribosomal protein S11	0	2	1	3
30S ribosomal protein S12	0	2	1	3
30S ribosomal protein S13	0	2	1	3
30S ribosomal protein S16	0	2	1	3
30S ribosomal protein S18	0	2	1	3
30S ribosomal protein S19	0	2	1	3
30S ribosomal protein S20	0	2	1	3
30S ribosomal protein S2	0	2	1	3
30S ribosomal protein S3	0	2	1	3
30S ribosomal protein S4	0	2	1	3
30S ribosomal protein S5	0	2	1	3
30S ribosomal protein S8	0	2	1	3
30S ribosomal protein S9	0	2	1	3
50S ribosomal protein L13	0	2	1	3
50S ribosomal protein L14	0	2	1	3
50S ribosomal protein L16	0	2	1	3
50S ribosomal protein L23	0	2	1	3
30S ribosomal protein S15	0	2	1	3
50S ribosomal protein L17	0	2	1	3
50S ribosomal protein L21	0	2	1	3
50S ribosomal protein L30	0	2	1	3
50S ribosomal protein L6	0	2	1	3
30S ribosomal protein S14	0	2	1	3
30S ribosomal protein S17	0	2	1	3
30S ribosomal protein S1	0	2	1	3
50S ribosomal protein L18	0	2	1	3
Chitinase B	0	1	0	1
Low molecular weight phosphotyrosine protein phosphatase	0	1	0	1
50S ribosomal protein L2	0	2	1	3
50S ribosomal protein L3	0	2	1	3
50S ribosomal protein L24	0	2	1	3
50S ribosomal protein L4	0	2	1	3
50S ribosomal protein L22	0	2	1	3
50S ribosomal protein L5	0	2	1	3
30S ribosomal protein S21	0	2	1	3
50S ribosomal protein L25	0	2	1	3
50S ribosomal protein L36 2	0	2	1	3
hexokinase-4 isoform 1	3	0	0	3
glucokinase regulatory protein	3	0	0	3
Ghrelin O-acyltransferase	0	1	0	1
UDP-glucuronosyltransferase 1A3	0	0	0	4
NPC1-like intracellular cholesterol transporter 1	0	1	0	1
Flavin reductase (NADPH)	0	0	1	1
Fatty acid-binding protein, liver	0	1	0	1
Peroxisome proliferator-activated receptor alpha	0	0	1	1
Kappa-type opioid receptor	0	10	4	15
Mu-type opioid receptor	0	6	2	13
Chain A, Uracil Phosphoribosyltransferase	0	1	0	1
Skn7p	0	0	0	1
Solute carrier family 22 member 8	0	0	0	2
Thymidylate synthase	0	4	0	5
Dipeptidyl peptidase 4	0	1	0	1
Acetylcholinesterase	0	4	0	4
Potassium voltage-gated channel subfamily C member 1	0	2	0	2
Gastrin/cholecystokinin type B receptor	0	1	0	1
Chain A, Dihydrofolate reductase	0	0	1	1
Thymidylate synthase	0	4	0	4
Dihydrofolate reductase	0	4	3	7
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Multidrug resistance associated protein	0	1	0	3
Coagulation factor X	0	5	0	5
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	2
Chain A, ACETYLCHOLINESTERASE	0	1	0	1
Chain A, Acetylcholinesterase	0	1	0	1
Acetylcholinesterase	0	3	0	3
Vascular endothelial growth factor receptor 1	0	1	2	3
Acetylcholinesterase	0	3	0	3
Vascular endothelial growth factor receptor 3	0	1	2	3
Vascular endothelial growth factor receptor 2	0	2	2	4
Prolyl endopeptidase	0	2	0	2
Carboxylic ester hydrolase	0	4	0	4
Gamma-aminobutyric acid	0	1	2	3
Gamma-aminobutyric acid receptor subunit rho-3	0	0	1	1
Hsf1 protein	0	0	3	3
Gamma-aminobutyric acid receptor subunit alpha-6	0	1	2	3
Gamma-aminobutyric acid receptor subunit gamma-2	0	1	2	3
Gamma-aminobutyric acid receptor subunit delta	0	1	2	3
Sodium- and chloride-dependent GABA transporter 1	0	5	0	5
Gamma-aminobutyric acid receptor subunit rho-1	0	0	2	2
Gamma-aminobutyric acid receptor subunit alpha-2	0	1	2	3
Gamma-aminobutyric acid receptor subunit alpha-3	0	1	2	3
Gamma-aminobutyric acid receptor subunit gamma-3	0	1	2	3
Gamma-aminobutyric acid receptor subunit rho-2	0	0	1	1
Sodium- and chloride-dependent GABA transporter 1	0	3	1	6
Sodium- and chloride-dependent taurine transporter	0	2	0	2
Sodium- and chloride-dependent GABA transporter 2	0	5	0	5
Sodium- and chloride-dependent GABA transporter 3	0	4	0	4
Sodium- and chloride-dependent GABA transporter 1	0	4	0	4
Sodium- and chloride-dependent GABA transporter 2	0	4	0	4
Sodium- and chloride-dependent GABA transporter 3	0	4	0	4
Sodium- and chloride-dependent betaine transporter	0	4	0	4
Sodium- and chloride-dependent betaine transporter	0	2	0	2
Sodium- and chloride-dependent GABA transporter 3	0	2	0	2
Gamma-aminobutyric acid receptor subunit beta-1	0	1	2	3
Gamma-aminobutyric acid receptor subunit alpha-1	0	2	2	4
Gamma-aminobutyric acid receptor subunit beta-3	0	1	2	3
4-aminobutyrate aminotransferase, mitochondrial	0	1	0	2
Sterol O-acyltransferase 1	0	0	1	1
Gamma-aminobutyric acid receptor subunit alpha-5	0	1	2	3
Gamma-aminobutyric acid receptor subunit pi	0	1	2	3
Gamma-aminobutyric acid receptor subunit alpha-4	0	1	2	3
Platelet glycoprotein VI	0	1	2	4
Gamma-aminobutyric acid receptor subunit theta	0	1	2	3
Sodium- and chloride-dependent GABA transporter 2	0	1	0	1
Gamma-aminobutyric acid receptor subunit gamma-1	0	1	2	3
Guanylate cyclase soluble subunit alpha-1	0	0	1	1
Guanylate cyclase soluble subunit beta-1	0	0	1	1
Glucagon-like peptide 1 receptor	0	0	1	1
Glucagon-like peptide 1 receptor	0	1	1	2
Glucagon receptor	0	0	1	1
Glucagon receptor	0	0	1	1
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2	0	1	0	1
Chain A, Glutamate Receptor Subunit 2	0	1	0	1
Chain B, Glutamate Receptor Subunit 2	0	1	0	1
Chain A, Slr1257 protein	0	0	1	1
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]	0	1	0	1
Metabotropic glutamate receptor 8	0	2	0	2
Metabotropic glutamate receptor 6	0	1	1	3
Excitatory amino acid transporter 4	0	1	0	1
Bifunctional aspartokinase/homoserine dehydrogenase 1	0	1	0	1
Prothrombin	0	4	3	7
Metabotropic glutamate receptor 1	0	3	1	4
Metabotropic glutamate receptor 2	0	1	1	2
Metabotropic glutamate receptor 3	0	1	1	2
Metabotropic glutamate receptor 4	0	2	1	3
Metabotropic glutamate receptor 5	0	1	1	2
Metabotropic glutamate receptor 6	0	1	1	2
Metabotropic glutamate receptor 7	0	1	1	2
Metabotropic glutamate receptor 5	0	1	1	3
Metabotropic glutamate receptor 8	0	0	1	1
Excitatory amino acid transporter 3	0	0	0	1
Glutamate racemase	0	0	0	1
Metabotropic glutamate receptor 8	0	2	1	3
Glutamate carboxypeptidase 2	0	1	0	1
Metabotropic glutamate receptor 1	0	1	1	3
Metabotropic glutamate receptor 2	0	3	2	6
Metabotropic glutamate receptor 7	0	1	1	3
Metabotropic glutamate receptor 3	0	1	1	3
Metabotropic glutamate receptor 4	0	1	1	3
Carbonic anhydrase-like protein, putative	0	0	0	5
Glutamate racemase	0	0	0	1
ATP-binding cassette sub-family C member 9	0	1	0	1
ATP synthase subunit beta, mitochondrial	0	1	0	1
ATP synthase subunit delta, mitochondrial	0	1	0	1
ATP synthase subunit gamma, mitochondrial	0	1	0	1
ATP synthase subunit epsilon, mitochondrial	0	1	0	1
Cholesteryl ester transfer protein	0	1	0	1
Solute carrier family 15 member 1	0	1	0	1
ATP-binding cassette sub-family C member 8	0	1	0	1
ATP-sensitive inward rectifier potassium channel 11	0	1	0	1
Solute carrier family 15 member 2	0	1	0	1
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E	0	0	1	1
Sodium- and chloride-dependent glycine transporter 1	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	7	0	8
Serine racemase	0	1	0	1
Sodium- and chloride-dependent glycine transporter 2	0	1	0	1
Pancreatic alpha-amylase	0	1	0	1
High mobility group protein B1	0	0	3	3
Tyrosine-protein phosphatase non-receptor type 1	0	4	0	6
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	1	1	2
High mobility group protein B1	0	0	0	1
Corticosteroid 11-beta-dehydrogenase isozyme 2	0	1	1	2
Canalicular multispecific organic anion transporter 1	0	3	0	5
POU domain, class 2, transcription factor 1	0	0	0	1
Ricin	0	1	0	1
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	0	0	1	1
Purine nucleoside phosphorylase	0	0	2	4
Chain A, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Chain B, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
neutrophil cytosol factor 1	0	1	0	1
Cocaine esterase	0	2	0	2
Vitamin D-binding protein	0	1	0	1
HLA class I histocompatibility antigen, A alpha chain	0	0	2	2
Integrin beta-1	0	2	0	2
Integrin alpha-4	0	2	0	2
Carbonyl reductase [NADPH] 1	0	0	0	1
5-hydroxytryptamine receptor 2A	0	1	0	1
AP-2 complex subunit sigma	0	1	0	1
N-acetyltransferase Eis	0	2	0	2
Calcitonin gene-related peptide type 1 receptor	0	1	0	1
Genome polyprotein	0	3	0	3
Zinc finger protein 664	0	1	0	1
Vesicular acetylcholine transporter	0	1	0	1
DNA repair and recombination protein RAD54-like isoform 1	0	0	0	1
Tryptophan 2,3-dioxygenase	0	3	0	4
Chain A, Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	0	1
Glycogen synthase kinase-3 beta	0	1	0	1
CDC-like kinase 1, isoform CRA_c	0	0	0	1
[Tau protein] kinase	0	1	0	1
dual specificity protein kinase CLK4	1	0	0	1
Dual specificity protein kinase CLK2	0	1	0	1
Dual specificity protein kinase CLK3	0	1	0	1
Dual specificity protein kinase CLK4	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 3	0	1	0	1
Cyclin-T1	0	1	0	1
Serine/threonine-protein kinase D3	0	3	4	7
Protein kinase C gamma type	0	4	1	5
Protein kinase C beta type	0	5	4	9
Tyrosine-protein kinase Lyn	0	2	3	5
Protein kinase C alpha type	0	5	4	9
Dual specificity protein kinase CLK1	0	1	0	1
Protein kinase C eta type	0	3	3	6
Sodium-dependent dopamine transporter	0	1	0	1
Neuromedin-B receptor	0	1	0	1
Protein kinase C iota type	0	3	4	7
Casein kinase I isoform delta	0	1	3	4
Casein kinase I isoform epsilon	0	1	3	4
Dual specificity protein kinase CLK1	0	1	3	4
Cyclin-dependent kinase 7	0	1	3	4
Cyclin-dependent kinase 9	0	1	3	4
Cyclin-H	0	1	0	1
Mitogen-activated protein kinase 1	0	1	0	1
Cyclin-A1	0	1	0	1
Protein kinase C epsilon type	0	5	3	8
Protein kinase C theta type	0	3	4	7
Protein kinase C zeta type	0	3	3	6
Protein kinase C delta type	0	4	4	8
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	2	3	5
Serine/threonine-protein kinase D1	0	3	3	6
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	0	1
Serine/threonine-protein kinase pim-3	0	1	2	3
Serine/threonine-protein kinase haspin	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 2	0	1	2	3
Dual specificity tyrosine-phosphorylation-regulated kinase 4	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 1B	0	2	3	5
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	2	0	3
N-glycosylase/DNA lyase	0	1	0	1
Aspartate aminotransferase, cytoplasmic	0	1	0	1
Cyclic GMP-AMP synthase	0	1	0	1
Toll-like receptor 9	0	1	0	1
Toll-like receptor 7	0	1	0	1
Uracil nucleotide/cysteinyl leukotriene receptor	0	3	0	3
Neutral amino acid transporter A	0	2	0	2
Asc-type amino acid transporter 1	0	1	0	1
Neutral amino acid transporter B(0)	0	2	0	2
Amino acid transporter	0	2	0	2
Chain A, Purine-nucleoside Phosphorylase	0	1	0	1
Chain C, Xanthine dehydrogenase/oxidase	0	0	1	1
Prostacyclin receptor	0	1	1	2
Chain A, PROTEIN (PROTEASE)	0	1	0	1
Chain B, PROTEIN (PROTEASE)	0	1	0	1
Chain A, PROTEIN (PROTEASE)	0	1	0	1
Chain B, PROTEIN (PROTEASE)	0	1	0	1
Chain A, HIV-1 PROTEASE	0	1	0	1
Chain B, HIV-1 PROTEASE	0	1	0	1
Chain A, HIV-II PROTEASE	0	1	0	1
Chain B, HIV-II PROTEASE	0	1	0	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, POL polyprotein	0	1	0	1
Chain B, POL polyprotein	0	1	0	1
Chain A, POL polyprotein	0	1	0	1
Chain B, POL polyprotein	0	1	0	1
Chain A, HIV-1 protease	0	1	0	1
Chain B, HIV-1 protease	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	1	0	1
Gag polyprotein	0	1	0	1
Gag-Pol polyprotein	0	1	0	1
Gag-Pol polyprotein	0	3	0	3
Gag-Pol polyprotein	0	1	0	1
Thromboxane-A synthase	0	0	0	1
Protease	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	2	0	2
Pteridine reductase 1	0	2	0	2
Chain A, membrane-associated prostaglandin E synthase-2	0	1	0	1
Phospholipase A2, major isoenzyme	0	1	0	1
Interleukin-8	0	1	0	1
Polyunsaturated fatty acid 5-lipoxygenase	0	2	0	3
Aldo-keto reductase family 1 member C4	0	1	0	1
Aldo-keto reductase family 1 member C3	0	3	0	3
C-X-C chemokine receptor type 3	0	3	0	3
Aldo-keto reductase family 1 member C2	0	2	0	2
Prostaglandin D2 receptor	0	2	0	2
Aldo-keto reductase family 1 member C1	0	2	0	2
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Cytosolic phospholipase A2 gamma	0	1	0	1
Prostaglandin D2 receptor 2	0	1	1	2
5-hydroxytryptamine receptor 1E	0	2	0	2
Cholecystokinin receptor type A	0	3	1	4
Gastrin/cholecystokinin type B receptor	0	2	0	2
Ornithine decarboxylase	0	0	0	2
Mitogen-activated protein kinase 1	0	2	3	5
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	0	0	1	1
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	0	0	1	1
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	0	0	1	1
Caspase-3	0	1	0	1
Caspase-4	0	1	0	1
Caspase-5	0	1	0	1
Caspase-9	0	1	0	1
Heparanase	0	0	1	1
Capsid protein	0	1	2	3
Potassium voltage-gated channel subfamily E member 1	0	3	0	3
Potassium voltage-gated channel subfamily KQT member 1	0	3	0	3
WRN	1	0	0	1
integrase, partial	0	1	0	1
lens epithelium-derived growth factor p75	0	1	0	1
Solute carrier family 15 member 1	0	1	0	1
SLC16A10 protein	0	0	0	4
Monocarboxylate transporter 10	0	0	0	4
phosphoglycerate kinase	2	0	0	2
CAAX prenyl protease 2 isoform 2	0	0	0	1
DNA primase	0	1	0	1
5-hydroxytryptamine receptor 2C	0	0	1	1
Neprilysin	0	1	0	1
Type-1 angiotensin II receptor	0	1	1	2
Chain A, Antigen Cd11a (p180)	0	1	0	1
Integrin beta-2	0	1	0	1
Intercellular adhesion molecule 1	0	1	0	1
Integrin alpha-L	0	1	1	2
Acyl-CoA:cholesterol acyltransferase	0	1	0	1
Prothrombin	0	2	0	2
Plasminogen	0	1	0	1
Tissue-type plasminogen activator	0	1	0	1
Trypsin-1	0	2	0	2
Trypsin-2	0	2	0	2
Trypsin-3	0	2	0	2
Acetylcholine receptor subunit epsilon	0	0	2	2
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Progesterone receptor	0	10	3	16
Androgen receptor	0	0	1	1
Cytochrome P450 1A2	0	1	0	3
Nociceptin receptor	0	1	0	1
Melatonin receptor type 1A	0	2	1	3
Melatonin receptor type 1C	0	0	1	1
Melatonin receptor type 1A	0	1	1	2
Melatonin receptor type 1B	0	2	1	3
Melatonin receptor type 1C	0	1	1	2
Melatonin receptor type 1B	0	1	1	2
Secreted chorismate mutase	0	1	0	1
Transient receptor potential cation channel subfamily M member 8	0	1	2	4
Transient receptor potential cation channel subfamily A member 1	0	0	4	4
UDP-glucose 6-dehydrogenase	0	1	0	1
UDP-glucose 6-dehydrogenase	0	1	0	1
UDP-glucuronosyltransferase 1A1	0	1	0	1
microphthalmia-associated transcription factor isoform 9	0	1	0	1
Tumor necrosis factor	0	2	0	2
Neuraminidase	0	1	0	1
Cystathionine gamma-lyase	0	2	0	2
Cystine/glutamate transporter	0	1	0	1
Hydroxyacid oxidase 1	0	1	0	1
Dihydrofolate reductase	0	5	0	6
galanin receptor type 3	0	2	0	2
Mas-related G-protein coupled receptor member X2	0	0	2	2
Aldehyde oxidase 1	0	1	0	1
Synaptic vesicular amine transporter	0	2	0	2
Dopamine beta-hydroxylase	0	2	0	2
Lactoperoxidase	0	1	0	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Aminopeptidase	0	1	0	1
Chain A, Methionine aminopeptidase	0	1	0	1
S-ribosylhomocysteine lyase	0	1	0	1
Adenylate cyclase type 5	0	0	0	1
S-adenosylmethionine synthase isoform type-1	0	0	0	1
S-adenosylmethionine synthase isoform type-2	0	0	0	1
Fatty acid synthase	0	1	0	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Thymidylate synthase	0	1	0	1
Thymidylate synthase	0	1	0	1
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]	0	1	0	1
transactivating tegument protein VP16 [Human herpesvirus 1]	0	2	0	2
nuclear receptor coactivator 3 isoform a	0	1	0	1
ATP-binding cassette sub-family C member 3	0	1	0	2
Dihydrofolate reductase	0	2	0	3
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	2	0	3
Thymidylate synthase	0	1	0	1
Tyrosine-protein kinase ABL1	0	2	4	6
Dihydrofolate reductase	0	1	0	1
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Folate receptor beta	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Folate receptor alpha	0	1	0	1
Histidine decarboxylase	0	1	3	4
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Bifunctional purine biosynthesis protein ATIC	0	2	0	2
Reduced folate transporter	0	2	0	2
6-phosphogluconate dehydrogenase, decarboxylating	0	2	0	2
Dihydrofolate reductase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Proton-coupled folate transporter	0	1	0	1
Nuclear receptor subfamily 1 group I member 2	0	0	1	1
5-hydroxytryptamine receptor 3B	0	3	0	3
Beta-1 adrenergic receptor	0	2	0	2
Thioredoxin reductase	0	1	0	1
Flavodoxin	0	0	0	1
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Cytochrome P450 11B1, mitochondrial	0	1	0	1
Cytochrome P450 11B2, mitochondrial	0	1	0	1
Chain A, PROGESTERONE RECEPTOR	0	1	0	1
Glucocorticoid receptor	0	1	0	1
Tegument protein VP16	0	0	1	1
Glucocorticoid receptor	0	3	2	6
Glucocorticoid receptor	0	1	1	2
Thyroid hormone receptor alpha	0	1	1	2
Thyroid hormone receptor beta	0	1	1	2
Progesterone receptor	0	0	1	1
Glucocorticoid receptor	0	1	0	1
Nuclear receptor corepressor 1	0	1	0	1
Leukotriene A-4 hydrolase	0	1	0	1
Nuclear receptor corepressor 2	0	1	0	1
Opioid receptor, delta 1b	0	1	0	1
Opioid receptor homologue	0	1	0	1
Acyl-CoA desaturase 1	0	2	0	2
Proteinase-activated receptor 1	0	2	1	3
Kappa-type opioid receptor	0	5	2	10
Nociceptin receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
Sialidase-4	0	1	0	1
Sialidase-1	0	1	0	1
Sialidase-3	0	1	0	1
UDP-glucuronosyltransferase 1A8	0	0	0	2
Nociceptin receptor	0	2	0	2
Somatostatin receptor type 1	0	1	0	1
Somatostatin receptor type 2	0	1	0	1
Somatostatin receptor type 4	0	1	0	1
Somatostatin receptor type 3	0	1	0	1
Somatostatin receptor type 5	0	1	0	1
Neuropeptide Y receptor type 1	0	2	0	2
Neuropeptide Y receptor type 2	0	2	0	2
Neurotensin receptor type 1	0	0	1	1
Neurotensin receptor type 2	0	1	1	3
Myelin basic protein	0	0	1	1
Neurotensin receptor type 1	0	1	1	2
Neurotensin receptor type 1	0	2	2	5
Neurotensin receptor type 2	0	2	1	3
Sortilin	0	1	0	1
Cholesteryl ester transfer protein	0	2	0	2
D-amino-acid oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 3	0	0	1	1
Nicotinamidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	0	1	1
Hydroxycarboxylic acid receptor 2	0	2	1	3
D-aspartate oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-4	0	1	0	1
Acetylcholine receptor subunit beta-like 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-7	0	3	0	3
Acetylcholine-binding protein	0	1	1	2
Neuronal acetylcholine receptor subunit beta-3	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-6	0	1	1	2
Cytochrome P450 2A13	0	2	2	4
Neuronal acetylcholine receptor subunit alpha-5	0	2	0	2
Liver carboxylesterase B-1	0	1	0	1
Neuronal acetylcholine receptor subunit beta-3	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	2	0	2
Soluble acetylcholine receptor	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-6	0	2	0	2
Integrin beta	0	0	1	1
Glycoprotein IIb	0	0	1	1
Phospholipase A2, membrane associated	0	0	0	1
Potassium voltage-gated channel subfamily A member 5	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
C-terminal-binding protein 1	1	0	0	1
Myosin light chain kinase, smooth muscle	0	1	3	4
Voltage-dependent L-type calcium channel subunit alpha-1D	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1F	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-4	0	1	0	1
Voltage-dependent P/Q-type calcium channel subunit alpha-1A	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1G	0	1	0	1
Voltage-dependent calcium channel gamma-3 subunit	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1H	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-3	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	3
Voltage-dependent calcium channel gamma-7 subunit	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-1	0	1	0	1
Voltage-dependent calcium channel gamma-1 subunit	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-2	0	1	0	1
Voltage-dependent R-type calcium channel subunit alpha-1E	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-4	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-3	0	1	0	1
Voltage-dependent calcium channel gamma-8 subunit	0	1	0	1
Voltage-dependent calcium channel gamma-6 subunit	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-2	0	2	0	2
Voltage-dependent T-type calcium channel subunit alpha-1I	0	1	0	1
Voltage-dependent calcium channel gamma-4 subunit	0	1	0	1
Voltage-dependent calcium channel gamma-5 subunit	0	1	0	1
Voltage-dependent calcium channel gamma-2 subunit	0	1	0	1
Sodium/iodide cotransporter	0	1	0	1
dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	0	0	1
Inhibitor of nuclear factor kappa-B kinase subunit alpha	0	1	2	3
Indoleamine 2,3-dioxygenase 1	0	4	0	5
cAMP-dependent protein kinase catalytic subunit alpha	0	1	3	4
cAMP-dependent protein kinase catalytic subunit gamma	0	1	2	3
cAMP-dependent protein kinase catalytic subunit beta	0	1	3	4
Sodium- and chloride-dependent betaine transporter	0	2	0	2
FAD-linked sulfhydryl oxidase ALR	0	0	0	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	1
Collagenase 3	0	3	0	3
Nitric oxide synthase, brain	0	1	0	1
Interleukin-6 receptor subunit alpha	0	1	0	1
Thyrotropin-releasing hormone receptor	0	1	0	1
Glycine receptor subunit alpha-4	0	1	0	1
Leukotriene B4 receptor 1	0	1	0	1
Lysine-specific demethylase 4E	0	1	0	1
Lysine-specific demethylase 6B	0	1	0	1
Kynurenine 3-monooxygenase	0	1	0	1
Lysine-specific demethylase 4A	0	1	0	1
Lysine-specific demethylase 5C	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	2	0	2
Peptidyl-prolyl cis-trans isomerase A	0	1	0	1
Methylcytosine dioxygenase TET2	0	1	0	1
Lysine-specific demethylase 7A	0	1	0	1
Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	0	1	0	1
Lysine-specific demethylase 5D	0	1	0	1
Lysine-specific demethylase 4C	0	1	0	1
Lysine-specific demethylase 5B	0	1	0	1
Histone lysine demethylase PHF8	0	1	0	1
Lysine-specific demethylase 2A	0	1	0	1
Lysine-specific demethylase 3A	0	1	0	1
MBT domain-containing protein 1	0	1	0	1
Lethal(3)malignant brain tumor-like protein 4	0	1	0	1
Lethal(3)malignant brain tumor-like protein 3	0	1	0	1
Lethal(3)malignant brain tumor-like protein 1	0	1	0	1
Oxytocin receptor	0	2	2	4
Vasopressin V1a receptor	0	1	0	1
Vasopressin V1a receptor	0	3	2	5
Vasopressin V1b receptor	0	1	1	2
Vasopressin V1b receptor	0	1	0	1
Oxytocin receptor	0	1	0	1
Oxytocin receptor	0	0	1	1
Vasopressin V2 receptor	0	1	0	1
Beta-adrenergic receptor kinase 1	0	1	0	1
Beta-adrenergic receptor kinase 1	0	1	5	6
Rhodopsin kinase GRK1	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
P2X purinoceptor 4	0	1	0	1
Rhodopsin kinase GRK1	0	1	2	3
P2X purinoceptor 4	0	1	0	1
Beta-adrenergic receptor kinase 1	0	0	0	1
G-protein coupled receptor 84	0	0	1	1
vasopressin V1b receptor	1	0	0	1
Arylacetamide deacetylase	0	0	0	1
Arylacetamide deacetylase	0	0	0	1
Arylacetamide deacetylase	0	0	0	1
Chain A, Immunoglobulin	0	0	1	1
Chain B, Immunoglobulin	0	0	1	1
Cholinesterase	0	2	0	2
Muscarinic acetylcholine receptor M5	0	1	1	3
Muscarinic acetylcholine receptor M3	0	1	1	3
Muscarinic acetylcholine receptor M2	0	1	1	3
Membrane primary amine oxidase	0	1	0	1
Chain A, AMINOPEPTIDASE	0	1	0	1
Chain A, AMINOPEPTIDASE	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Intestinal-type alkaline phosphatase	0	3	0	3
Intestinal-type alkaline phosphatase	0	1	0	1
5'-nucleotidase	0	2	0	2
E3 ubiquitin-protein ligase XIAP	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	1	0	1
Phospholipase A-2-activating protein	0	3	0	3
Alpha-1B adrenergic receptor	0	2	0	2
Muscarinic acetylcholine receptor DM1	0	2	0	2
CDGSH iron-sulfur domain-containing protein 1	0	1	0	1
Free fatty acid receptor 1	0	0	1	1
Peroxisome proliferator-activated receptor gamma	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	1	0	1
Carnitine O-palmitoyltransferase 1, liver isoform	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	1	0	1
CDGSH iron-sulfur domain-containing protein 2	0	1	0	1
Transforming growth factor beta-1 proprotein	0	1	0	1
Mothers against decapentaplegic homolog 3	0	1	0	1
Alpha-1A adrenergic receptor	0	1	1	2
Beta-casein	0	1	0	1
Interstitial collagenase	0	2	1	3
Alpha-2A adrenergic receptor	0	1	0	1
Alpha-mannosidase 2C1	0	0	1	1
Bromodomain-containing protein 2	0	2	0	2
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	2	0	2
luciferase	0	0	0	1
Glutamine synthetase	0	0	1	1
Nociceptin receptor	0	0	1	1
Glutamate 5-kinase	0	0	0	1
Neuromedin-K receptor	0	0	1	1
Beta-2 adrenergic receptor	0	1	0	1
Nuclear receptor subfamily 2 group E member 1	0	0	2	2
NADH-cytochrome b5 reductase 3	0	1	0	1
Thyroid peroxidase	0	1	0	1
Taste receptor type 2 member 38	0	0	1	2
Interleukin-5	0	1	0	1
Interleukin-5	0	1	0	1
Interleukin-5 receptor subunit alpha	0	1	0	1
Polypeptide N-acetylgalactosaminyltransferase 2	0	1	0	1
Pyridoxal kinase	0	0	3	4
Chain A, APH(2')-Id	0	1	0	1
glucose-6-phosphate dehydrogenase	0	1	0	1
hexokinase	0	1	0	1
galactokinase	1	0	0	1
Maltase-glucoamylase, intestinal	0	1	0	1
NUAK family SNF1-like kinase 1	0	1	2	3
B2 bradykinin receptor	0	1	0	1
Arginase	0	1	0	1
Pancreatic triacylglycerol lipase	0	1	0	1
Urokinase-type plasminogen activator	0	1	0	1
Chymotrypsin-like elastase family member 1	0	1	0	1
Protein E6	0	1	0	1
Neuraminidase	0	1	0	1
Beta-lactamase	0	1	0	1
Glycogen phosphorylase, liver form	0	1	3	4
Epoxide hydrolase 1	0	1	0	1
Tyrosine-protein kinase Yes	0	1	3	4
Proto-oncogene tyrosine-protein kinase receptor Ret	0	1	3	4
Insulin-like growth factor 1 receptor	0	1	3	4
Hepatocyte growth factor receptor	0	1	3	4
Heterogeneous nuclear ribonucleoprotein A1	0	0	1	1
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Alpha-amylase 1A	0	1	0	1
Lysosomal alpha-glucosidase	0	1	0	1
Malate dehydrogenase	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 2	0	1	0	1
Cyclin-dependent kinase 4	0	1	3	4
Sucrase-isomaltase, intestinal	0	1	0	1
Serine/threonine-protein kinase B-raf	0	1	3	4
Polyunsaturated fatty acid lipoxygenase ALOX15	0	1	0	1
Chymotrypsinogen B	0	1	0	1
Polyunsaturated fatty acid lipoxygenase ALOX12	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal	0	1	0	1
G1/S-specific cyclin-D1	0	1	0	1
Phosphatidylinositol 3-kinase regulatory subunit alpha	0	1	0	1
Cytosol aminopeptidase	0	1	0	1
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	0	1	0	1
Tyrosine-protein kinase receptor UFO	0	1	2	3
RAC-alpha serine/threonine-protein kinase	0	2	3	5
Macrophage metalloelastase	0	1	0	1
Glutathione reductase	0	1	0	1
1-deoxy-D-xylulose 5-phosphate reductoisomerase	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	2	0	2
Serine/threonine-protein kinase Nek2	0	1	3	4
Oligo-1,6-glucosidase IMA1	0	1	0	1
Serine/threonine-protein kinase PLK1	0	1	3	4
Monocarboxylate transporter 1	0	1	0	1
Anthrax toxin receptor 2	0	1	0	1
Aldo-keto reductase family 1 member B1	0	1	0	1
Heat shock factor protein 1	0	1	0	1
Sorbitol dehydrogenase	0	1	0	1
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	1	0	1
Dual specificity mitogen-activated protein kinase kinase 1	0	1	3	4
Focal adhesion kinase 1	0	1	3	4
Calcium/calmodulin-dependent protein kinase type II subunit beta	0	1	2	3
ELAV-like protein 3	0	1	0	1
ELAV-like protein 1	0	1	0	1
Serine/threonine-protein kinase N1	0	1	3	4
Probable maltase-glucoamylase 2	0	1	0	1
Monocarboxylate transporter 2	0	1	0	1
Aldo-keto reductase family 1 member C21	0	2	0	2
3-oxoacyl-acyl-carrier protein reductase	0	1	0	1
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)	0	1	0	1
Chymotrypsin-C	0	1	0	1
G-protein coupled receptor 35	0	1	1	2
Serine/threonine-protein kinase Nek6	0	1	2	3
ALK tyrosine kinase receptor	0	1	2	3
Prolyl 4-hydroxylase, beta polypeptide	0	0	0	1
Gastric inhibitory polypeptide receptor	0	1	0	1
Voltage-gated sodium channel Nav1.5 cardiac isoform	0	1	0	1
DNA topoisomerase 1	0	1	0	1
Chromaffin granule amine transporter	0	1	0	1
Synaptic vesicular amine transporter	0	2	1	3
Synaptic vesicular amine transporter	0	1	0	1
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR	0	0	1	1
Retinol-binding protein 4	0	0	1	1
Beta-lactoglobulin	0	0	1	1
Chain A, Activated Factor Xa Heavy Chain	0	1	0	1
Coagulation factor XII	0	1	0	1
Suppressor of tumorigenicity 14 protein	0	1	0	1
Acetylcholine receptor subunit epsilon	0	1	0	1
Cholinesterase	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Sphingosine kinase 2	0	2	0	2
Sphingosine kinase 1	0	1	0	1
Leukotriene C4 synthase	0	0	2	2
Bone morphogenetic protein receptor type-1B	0	0	3	3
Membrane-associated progesterone receptor component 1	0	0	2	2
Cell division cycle 7-related protein kinase	0	0	2	2
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	0	0	2	2
Serine/threonine-protein kinase PLK4	0	0	3	3
Serine/threonine-protein kinase 25	0	0	2	2
ATP-dependent RNA helicase DDX3X	0	0	3	3
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	0	0	2	2
Citron Rho-interacting kinase	0	0	3	3
Serine/threonine-protein kinase RIO3	0	0	2	2
Dual specificity mitogen-activated protein kinase kinase 7	0	1	2	3
Serine/threonine-protein kinase Chk1	0	1	3	4
Inhibitor of nuclear factor kappa-B kinase subunit beta	0	0	2	3
Peripheral plasma membrane protein CASK	0	0	2	2
Aurora kinase A	0	0	3	3
Cyclin-G-associated kinase	0	0	3	3
Serine/threonine-protein kinase DCLK1	0	0	2	2
Muscle, skeletal receptor tyrosine-protein kinase	0	0	2	2
Ephrin type-B receptor 6	0	0	3	3
Peroxisomal acyl-coenzyme A oxidase 3	0	0	3	3
Mitogen-activated protein kinase kinase kinase 13	0	0	2	2
Death-associated protein kinase 3	0	0	2	2
Receptor-interacting serine/threonine-protein kinase 2	0	0	3	3
Mitotic checkpoint serine/threonine-protein kinase BUB1	0	0	3	3
Dynamin-like 120 kDa protein, mitochondrial	0	0	3	3
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	0	0	2	2
Tyrosine-protein kinase JAK2	0	3	4	9
Eukaryotic translation initiation factor 5B	0	0	2	2
Rho-associated protein kinase 2	0	1	3	4
Serine/threonine-protein kinase ULK1	0	0	3	3
Serine/threonine-protein kinase/endoribonuclease IRE1	0	0	3	3
Ribosomal protein S6 kinase alpha-5	0	1	3	4
U5 small nuclear ribonucleoprotein 200 kDa helicase	0	0	3	3
Ribosomal protein S6 kinase alpha-4	0	0	3	3
Serine/threonine-protein kinase 16	0	0	3	3
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	0	0	2	2
Serine/threonine-protein kinase PAK 3	0	0	2	2
Cyclin-dependent kinase-like 5	0	0	3	3
Serine/threonine-protein kinase 17B	0	0	2	2
Serine/threonine-protein kinase 10	0	0	3	3
Cyclin-dependent kinase 14	0	0	2	2
Structural maintenance of chromosomes protein 2	0	0	2	2
Mitogen-activated protein kinase kinase kinase 6	0	0	3	3
Serine/threonine-protein kinase OSR1	0	0	2	2
Mitogen-activated protein kinase kinase kinase kinase 4	0	0	3	3
Serine/threonine-protein kinase LATS1	0	0	3	3
Serine/threonine-protein kinase PAK 4	0	0	3	3
Serine/threonine-protein kinase Chk2	0	0	2	2
Proto-oncogene tyrosine-protein kinase Src	0	0	1	1
Low-density lipoprotein receptor	0	1	0	1
Fibronectin	0	1	0	1
RAF proto-oncogene serine/threonine-protein kinase	0	1	2	3
High affinity nerve growth factor receptor	0	0	3	3
ADP/ATP translocase 2	0	0	3	3
Tyrosine-protein kinase Fes/Fps	0	0	3	3
Macrophage colony-stimulating factor 1 receptor	0	1	2	3
Signal recognition particle receptor subunit alpha	0	0	3	3
Cytochrome c1, heme protein, mitochondrial	0	0	3	3
Tyrosine-protein kinase HCK	0	1	3	4
Proto-oncogene tyrosine-protein kinase ROS	0	0	2	2
Macrophage colony-stimulating factor 1 receptor	0	1	0	1
Tyrosine-protein kinase Fgr	0	0	3	3
Wee1-like protein kinase 2	0	0	2	2
Uncharacterized serine/threonine-protein kinase SBK3	0	0	2	2
Serine/threonine-protein kinase A-Raf	0	0	3	3
Mast/stem cell growth factor receptor Kit	0	1	2	3
Glycogen phosphorylase, brain form	0	0	3	3
Breakpoint cluster region protein	0	2	3	5
ADP/ATP translocase 3	0	0	3	3
cAMP-dependent protein kinase type II-alpha regulatory subunit	0	0	2	2
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
Insulin receptor-related protein	0	0	2	2
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	0	0	3	3
Platelet-derived growth factor receptor alpha	0	1	2	3
Tyrosine-protein kinase Fer	0	0	3	3
General transcription and DNA repair factor IIH helicase subunit XPD	0	0	3	3
Interferon-induced, double-stranded RNA-activated protein kinase	0	0	2	2
Ras-related protein Rab-6A	0	0	3	3
Serine/threonine-protein kinase MAK	0	0	2	2
Cyclin-dependent kinase 11B	0	0	2	2
Ephrin type-A receptor 1	0	0	3	3
Receptor tyrosine-protein kinase erbB-3	0	0	2	2
Multifunctional protein ADE2	0	0	3	3
Ferrochelatase, mitochondrial	0	0	3	3
Ribosomal protein S6 kinase beta-1	0	1	3	4
Tyrosine-protein kinase JAK1	0	3	4	9
Probable ATP-dependent RNA helicase DDX6	0	0	3	3
Activin receptor type-2A	0	0	2	2
MAP/microtubule affinity-regulating kinase 3	0	0	3	3
Ephrin type-A receptor 2	0	1	3	4
Ephrin type-A receptor 3	0	0	2	2
Ephrin type-A receptor 8	0	0	2	2
Ephrin type-B receptor 2	0	0	3	3
Leukocyte tyrosine kinase receptor	0	0	2	2
Non-receptor tyrosine-protein kinase TYK2	0	3	4	9
UMP-CMP kinase	0	0	2	2
Phosphatidylethanolamine-binding protein 1	0	0	2	2
Wee1-like protein kinase	0	0	3	3
Heme oxygenase 2	0	0	3	3
Mitogen-activated protein kinase 4	0	0	2	2
S-adenosylmethionine synthase isoform type-2	0	0	3	3
DnaJ homolog subfamily A member 1	0	0	3	3
RAC-beta serine/threonine-protein kinase	0	0	3	3
G protein-coupled receptor kinase 4	0	0	2	2
Dual specificity protein kinase TTK	0	0	3	3
DNA replication licensing factor MCM4	0	0	2	2
Myosin-10	0	0	2	2
Tyrosine-protein kinase receptor Tie-1	0	0	2	2
Dual specificity mitogen-activated protein kinase kinase 2	0	0	3	3
Bone morphogenetic protein receptor type-1A	0	0	3	3
Activin receptor type-1B	0	0	3	3
TGF-beta receptor type-1	0	0	3	3
Serine/threonine-protein kinase receptor R3	0	0	3	3
TGF-beta receptor type-2	0	0	3	3
Tyrosine-protein kinase CSK	0	1	3	4
Glycine--tRNA ligase	0	0	3	3
Exosome RNA helicase MTR4	0	0	3	3
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	2	3
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	0	0	2	2
Megakaryocyte-associated tyrosine-protein kinase	0	0	2	2
Tyrosine-protein kinase Tec	0	1	3	4
Tyrosine-protein kinase TXK	0	1	2	3
Tyrosine-protein kinase ABL2	0	0	3	3
Tyrosine-protein kinase FRK	0	0	3	3
G protein-coupled receptor kinase 6	0	0	2	2
Tyrosine-protein kinase ZAP-70	0	0	2	2
26S proteasome regulatory subunit 6B	0	0	3	3
Mitogen-activated protein kinase 8	0	1	3	4
Mitogen-activated protein kinase 9	0	0	3	3
Dual specificity mitogen-activated protein kinase kinase 4	0	0	2	2
Dual specificity mitogen-activated protein kinase kinase 3	0	0	3	3
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	0	0	2	2
Casein kinase I isoform alpha	0	0	3	3
MAP kinase-activated protein kinase 2	0	1	3	4
Cyclin-dependent kinase 8	0	0	2	2
Elongation factor Tu, mitochondrial	0	0	3	3
Cysteine--tRNA ligase, cytoplasmic	0	0	3	3
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	0	0	3	3
Dual specificity protein kinase CLK2	0	0	3	3
Dual specificity protein kinase CLK3	0	0	3	3
Ras-related protein Rab-27A	0	0	2	2
Tyrosine-protein kinase Blk	0	2	2	4
Interleukin-1 receptor-associated kinase 1	0	0	3	3
Ribosomal protein S6 kinase alpha-3	0	1	3	4
Cytoplasmic tyrosine-protein kinase BMX	0	1	2	3
cAMP-dependent protein kinase catalytic subunit PRKX	0	0	2	2
Serine/threonine-protein kinase Nek3	0	0	3	3
Serine/threonine-protein kinase Nek4	0	0	2	2
Tyrosine-protein kinase JAK3	0	3	3	9
Dual specificity mitogen-activated protein kinase kinase 6	0	0	3	3
LIM domain kinase 1	0	0	3	3
LIM domain kinase 2	0	0	3	3
Tyrosine--tRNA ligase, cytoplasmic	0	0	3	3
Ephrin type-B receptor 3	0	0	3	3
Ephrin type-A receptor 5	0	0	3	3
Ephrin type-B receptor 4	0	0	3	3
Ephrin type-B receptor 1	0	0	2	2
Ephrin type-A receptor 4	0	0	3	3
Hormonally up-regulated neu tumor-associated kinase	0	0	2	2
Serine/threonine-protein kinase SIK1	0	0	2	2
Receptor-interacting serine/threonine-protein kinase 4	0	0	2	2
Ras-related protein Rab-10	0	0	3	3
Cell division control protein 2 homolog	0	0	2	2
Actin-related protein 3	0	0	3	3
Actin-related protein 2	0	0	2	2
Calcium-dependent protein kinase 1	0	0	2	2
GTP-binding nuclear protein Ran	0	0	3	3
Ras-related C3 botulinum toxin substrate 1	0	0	1	1
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	0	0	2	2
SRSF protein kinase 2	0	0	2	2
Casein kinase I isoform gamma-2	0	0	3	3
Mitogen-activated protein kinase kinase kinase 9	0	0	2	2
Serine/threonine-protein kinase PknB	0	0	2	2
Cyclin-dependent kinase 3	0	0	2	2
Cyclin-dependent kinase-like 1	0	0	2	2
Cyclin-dependent kinase 16	0	0	3	3
Cyclin-dependent kinase 17	0	0	3	3
ATP-dependent 6-phosphofructokinase, platelet type	0	0	3	3
Mitogen-activated protein kinase kinase kinase 10	0	0	2	2
DNA topoisomerase 2-beta	0	0	3	3
Activin receptor type-1	0	0	3	3
Macrophage-stimulating protein receptor	0	0	3	3
Tyrosine-protein kinase BTK	0	1	3	4
Tyrosine-protein kinase receptor TYRO3	0	0	2	2
Cyclin-dependent kinase 18	0	0	3	3
Activated CDC42 kinase 1	0	0	3	3
Epithelial discoidin domain-containing receptor 1	0	2	3	5
Tyrosine-protein kinase ITK/TSK	0	1	2	3
Myotonin-protein kinase	0	0	2	2
Mitogen-activated protein kinase kinase kinase kinase 2	0	0	3	3
Mitogen-activated protein kinase kinase kinase 12	0	0	2	2
Tyrosine-protein kinase Mer	0	0	3	3
Serine/threonine-protein kinase 4	0	0	3	3
Dual specificity mitogen-activated protein kinase kinase 5	0	0	3	3
Mitogen-activated protein kinase 7	0	0	3	3
Serine/threonine-protein kinase PAK 2	0	0	3	3
Serine/threonine-protein kinase 3	0	0	3	3
Mitogen-activated protein kinase kinase kinase 1	0	0	3	3
cGMP-dependent protein kinase 2	0	0	2	2
Integrin-linked protein kinase	0	0	3	3
Rho-associated protein kinase 1	0	0	3	3
Non-receptor tyrosine-protein kinase TNK1	0	0	3	3
Serine/threonine-protein kinase PRP4 homolog	0	0	2	2
Receptor-interacting serine/threonine-protein kinase 1	0	0	2	2
Calcium/calmodulin-dependent protein kinase type II subunit gamma	0	0	3	3
Calcium/calmodulin-dependent protein kinase type II subunit delta	0	0	3	3
Activin receptor type-2B	0	0	3	3
Bone morphogenetic protein receptor type-2	0	0	3	3
Protein-tyrosine kinase 6	0	0	3	3
cGMP-dependent protein kinase 1	0	0	3	3
Cyclin-dependent kinase 13	0	0	3	3
Calcium/calmodulin-dependent protein kinase type 1	0	0	2	2
Inhibitor of nuclear factor kappa-B kinase subunit epsilon	0	0	3	3
Protein-tyrosine kinase 2-beta	0	0	3	3
Maternal embryonic leucine zipper kinase	0	0	3	3
Structural maintenance of chromosomes protein 1A	0	0	2	2
Chromodomain-helicase-DNA-binding protein 4	0	0	3	3
Serine/threonine-protein kinase 38	0	0	2	2
Receptor tyrosine-protein kinase erbB-4	0	1	2	3
Ribosomal protein S6 kinase alpha-2	0	0	2	2
Ephrin type-A receptor 7	0	0	2	2
Delta(24)-sterol reductase	0	0	2	2
Ribosomal protein S6 kinase alpha-1	0	0	3	3
Dual specificity testis-specific protein kinase 1	0	0	3	3
Serine/threonine-protein kinase STK11	0	0	3	3
NT-3 growth factor receptor	0	0	2	2
Serine/threonine-protein kinase N2	0	0	3	3
Calcium/calmodulin-dependent protein kinase type IV	0	0	3	3
Mitogen-activated protein kinase kinase kinase 11	0	0	3	3
BDNF/NT-3 growth factors receptor	0	0	2	2
Mitogen-activated protein kinase 6	0	0	2	2
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	0	0	2	2
Discoidin domain-containing receptor 2	0	2	3	5
AP2-associated protein kinase 1	0	0	3	3
Myosin light chain kinase 3	0	0	3	3
Serine/threonine-protein kinase SBK1	0	0	2	2
Mitogen-activated protein kinase kinase kinase 19	0	0	2	2
Putative heat shock protein HSP 90-beta 2	0	0	3	3
Serine/threonine-protein kinase TNNI3K	0	0	2	2
Rab-like protein 3	0	0	2	2
Leucine-rich repeat serine/threonine-protein kinase 2	0	0	2	2
Serine/threonine-protein kinase MRCK alpha	0	0	3	3
Serine/threonine-protein kinase MRCK gamma	0	0	3	3
Acyl-CoA dehydrogenase family member 10	0	0	3	3
Serine/threonine-protein kinase Nek5	0	0	2	2
Serine/threonine-protein kinase N3	0	0	2	2
Serine/threonine-protein kinase ULK3	0	0	3	3
Dual serine/threonine and tyrosine protein kinase	0	0	2	2
Mitogen-activated protein kinase kinase kinase 15	0	0	2	2
Uncharacterized protein FLJ45252	0	0	3	3
Acyl-CoA dehydrogenase family member 11	0	0	2	2
Serine/threonine-protein kinase/endoribonuclease IRE2	0	0	3	3
Serine/threonine-protein kinase MARK2	0	0	3	3
ATP-dependent RNA helicase DHX30	0	0	3	3
Serine/threonine-protein kinase TAO1	0	0	3	3
STE20-related kinase adapter protein alpha	0	0	3	3
Myosin-14	0	0	3	3
AarF domain-containing protein kinase 1	0	0	3	3
Serine/threonine-protein kinase tousled-like 2	0	0	2	2
Serine/threonine-protein kinase 32C	0	0	2	2
Serine/threonine-protein kinase VRK2	0	0	2	2
Myosin light chain kinase family member 4	0	0	2	2
Homeodomain-interacting protein kinase 1	0	0	2	2
Calcium/calmodulin-dependent protein kinase type 1D	0	0	2	2
Mitogen-activated protein kinase kinase kinase kinase 3	0	0	3	3
Cyclin-dependent kinase-like 3	0	0	2	2
MAP kinase-activated protein kinase 5	0	1	3	4
Serine/threonine-protein kinase BRSK2	0	0	2	2
Serine/threonine-protein kinase NIM1	0	0	2	2
Serine/threonine-protein kinase ULK2	0	0	2	2
Misshapen-like kinase 1	0	0	3	3
Serine/threonine-protein kinase DCLK2	0	0	2	2
Calcium/calmodulin-dependent protein kinase kinase 1	0	0	2	2
Casein kinase I isoform alpha-like	0	0	2	2
Proprotein convertase subtilisin/kexin type 9	0	1	0	1
Homeodomain-interacting protein kinase 4	0	0	2	2
Myosin-IIIa	0	0	2	2
Ankyrin repeat and protein kinase domain-containing protein 1	0	0	2	2
Serine/threonine-protein kinase Nek11	0	0	2	2
Atypical kinase COQ8A, mitochondrial	0	0	3	3
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	0	0	3	3
Mitogen-activated protein kinase 15	0	0	3	3
Serine/threonine-protein kinase Nek9	0	0	3	3
Serine/threonine-protein kinase BRSK1	0	0	2	2
Serine/threonine-protein kinase 35	0	0	2	2
Serine/threonine-protein kinase Nek7	0	0	2	2
Rhodopsin kinase GRK7	0	0	2	2
Serine/threonine-protein kinase 32A	0	0	2	2
Myosin-IIIb	0	0	2	2
ATP-dependent RNA helicase DDX1	0	0	3	3
Cyclin-dependent kinase-like 2	0	0	2	2
Mitogen-activated protein kinase kinase kinase kinase 1	0	0	3	3
Serine/threonine-protein kinase Sgk3	0	0	2	2
Atypical kinase COQ8B, mitochondrial	0	0	2	2
MAP/microtubule affinity-regulating kinase 4	0	0	3	3
Calcium/calmodulin-dependent protein kinase type 1G	0	0	3	3
Serine/threonine-protein kinase Nek1	0	0	3	3
Cyclin-dependent kinase 15	0	0	2	2
PAS domain-containing serine/threonine-protein kinase	0	0	3	3
Calcium/calmodulin-dependent protein kinase kinase 2	0	0	3	3
EKC/KEOPS complex subunit TP53RK	0	0	3	3
Dual specificity testis-specific protein kinase 2	0	0	3	3
SRSF protein kinase 1	0	0	2	2
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	0	0	3	3
Mitogen-activated protein kinase kinase kinase 5	0	0	3	3
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	0	0	2	2
Mitogen-activated protein kinase kinase kinase 3	0	0	3	3
Eukaryotic translation initiation factor 2-alpha kinase 1	0	0	3	3
Serine/threonine-protein kinase RIO1	0	0	2	2
MAP kinase-interacting serine/threonine-protein kinase 1	0	0	2	2
Serine/threonine-protein kinase RIO2	0	0	2	2
Cyclin-dependent kinase 19	0	0	2	2
Transient receptor potential cation channel subfamily M member 6	0	0	2	2
Testis-specific serine/threonine-protein kinase 1	0	0	2	2
Serine/threonine-protein kinase 33	0	0	2	2
Nucleolar GTP-binding protein 1	0	0	3	3
Serine/threonine-protein kinase D2	0	0	3	3
Serine/threonine-protein kinase DCLK3	0	0	2	2
NUAK family SNF1-like kinase 2	0	0	2	2
RNA cytidine acetyltransferase	0	0	3	3
Serine/threonine-protein kinase SIK2	0	0	3	3
Myosin light chain kinase 2, skeletal/cardiac muscle	0	0	2	2
STE20-like serine/threonine-protein kinase	0	0	3	3
Serine/threonine-protein kinase TAO3	0	0	3	3
Homeodomain-interacting protein kinase 2	0	0	2	2
Tyrosine-protein kinase Srms	0	0	2	2
Homeodomain-interacting protein kinase 3	0	0	2	2
Serine/threonine-protein kinase PLK3	0	0	2	2
dCTP pyrophosphatase 1	0	0	3	3
Dual specificity protein kinase CLK4	0	0	3	3
Casein kinase I isoform gamma-1	0	0	3	3
Serine/threonine-protein kinase PAK 6	0	0	2	2
SNF-related serine/threonine-protein kinase	0	0	2	2
Serine/threonine-protein kinase LATS2	0	0	2	2
Serine/threonine-protein kinase 36	0	0	2	2
Phenylalanine--tRNA ligase beta subunit	0	0	3	3
Isoleucine--tRNA ligase, mitochondrial	0	0	2	2
BMP-2-inducible protein kinase	0	0	3	3
Obg-like ATPase 1	0	0	2	2
Midasin	0	0	3	3
Interleukin-1 receptor-associated kinase 4	0	0	3	3
Serine/threonine-protein kinase 32B	0	0	2	2
Mitogen-activated protein kinase kinase kinase 20	0	0	3	3
Cyclin-dependent kinase 12	0	0	3	3
Serine/threonine-protein kinase PLK2	0	0	2	2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	0	0	2	2
Serine/threonine-protein kinase MARK1	0	0	2	2
Serine/threonine-protein kinase pim-2	0	0	2	2
Serine/threonine-protein kinase PAK 5	0	0	2	2
Serine/threonine-protein kinase 26	0	0	3	3
eIF-2-alpha kinase GCN2	0	0	2	2
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	0	0	3	3
Serine/threonine-protein kinase NLK	0	0	3	3
Serine/threonine-protein kinase 17A	0	0	2	2
STE20/SPS1-related proline-alanine-rich protein kinase	0	0	2	2
Ephrin type-A receptor 6	0	0	2	2
Serine/threonine-protein kinase TBK1	0	1	3	4
Septin-9	0	0	3	3
Death-associated protein kinase 2	0	0	2	2
Potassium voltage-gated channel subfamily D member 3	0	1	0	1
Ribosomal protein S6 kinase alpha-6	0	0	3	3
TRAF2 and NCK-interacting protein kinase	0	0	3	3
Serine/threonine-protein kinase tousled-like 1	0	0	2	2
Serine/threonine-protein kinase TAO2	0	0	3	3
SRSF protein kinase 3	0	0	2	2
Serine/threonine-protein kinase ICK	0	0	3	3
Cyclin-dependent kinase 11A	0	0	2	2
Aurora kinase C	0	0	2	2
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	0	2	2
RAC-gamma serine/threonine-protein kinase	0	0	3	3
Serine/threonine-protein kinase 38-like	0	0	2	2
Microtubule-associated serine/threonine-protein kinase 1	0	0	2	2
Serine/threonine-protein kinase SIK3	0	0	3	3
Mitogen-activated protein kinase kinase kinase 2	0	0	3	3
Thyroid hormone receptor-associated protein 3	0	0	3	3
Mitogen-activated protein kinase kinase kinase kinase 5	0	0	3	3
Receptor-interacting serine/threonine-protein kinase 3	0	0	3	3
Serine/threonine-protein kinase MRCK beta	0	0	3	3
Interleukin-1 receptor-associated kinase 3	0	0	3	3
Serine/threonine-protein kinase 24	0	0	3	3
Casein kinase I isoform gamma-3	0	0	3	3
Mitogen-activated protein kinase kinase kinase 4	0	0	3	3
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, 146aa long hypothetical transcriptional regulator	0	0	1	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain B, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain C, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Anthranilate phosphoribosyltransferase	0	1	0	1
Estrogen receptor beta	0	0	0	1
Polymerase acidic protein	0	0	1	1
Tyrosine-protein phosphatase YopH	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	1	0	1
Estrogen receptor	0	0	0	1
Ubiquitin-like domain-containing CTD phosphatase 1	0	1	0	1
LMP1 [Human herpesvirus 4]	0	0	0	1
Type-1 angiotensin II receptor	0	1	0	1
Amine oxidase [flavin-containing] A	0	0	0	1
Amine oxidase [flavin-containing] B	0	0	0	1
Transcriptional activator protein LuxR	0	2	0	2
photoreceptor-specific nuclear receptor	0	1	0	1
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	1	0	1
Eukaryotic translation initiation factor 4E	0	0	1	1
Adenine phosphoribosyltransferase	0	0	1	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	1	0	1
Electron transfer flavoprotein subunit beta	0	0	1	1
Choline-phosphate cytidylyltransferase A	0	0	1	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	4	2	6
Peptidyl-prolyl cis-trans isomerase FKBP1B	0	0	2	2
Peptidyl-prolyl cis-trans isomerase FKBP5	0	2	0	2
Peroxisomal acyl-coenzyme A oxidase 1	0	0	1	1
Uncharacterized aarF domain-containing protein kinase 5	0	0	2	2
Programmed cell death protein 4	0	0	1	1
Regulatory-associated protein of mTOR	0	1	0	1
Target of rapamycin complex subunit LST8	0	1	0	1
Serine/threonine-protein kinase mTOR	0	1	0	1
Free fatty acid receptor 3	0	0	1	1
Chain A, Mineralocorticoid receptor	0	1	0	1
Chain A, Mineralocorticoid receptor	0	1	0	1
Orexin receptor type 1	0	0	0	1
Cathepsin B	0	1	0	1
Tyrosinase	0	1	0	1
NAD(P)H dehydrogenase [quinone] 1	0	0	0	2
Chain A, MALTOPORIN	0	0	1	1
Chain B, MALTOPORIN	0	0	1	1
Transcription regulator protein BACH1	0	1	0	1
Transcription factor MafK	0	1	0	1
Macrophage migration inhibitory factor	0	1	0	1
NAD	0	0	0	1
Quinone oxidoreductase	0	0	0	3
Kelch-like ECH-associated protein 1	0	1	2	3
Nuclear factor erythroid 2-related factor 2	0	0	0	1
Kelch-like ECH-associated protein 1	0	0	0	1
D(2) dopamine receptor	0	1	0	1
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	0	2	0	2
Splicing factor 3B subunit 3	0	1	0	1
Chain A, CES1 protein	0	1	0	1
Lysosomal acid glucosylceramidase	0	0	1	1
Protein kinase C alpha type	0	1	0	1
Protein kinase C delta type	0	1	0	1
Protein kinase C epsilon type	0	1	0	1
Protein kinase C zeta type	0	1	0	1
Steroid hormone receptor ERR1	0	1	0	1
Estrogen-related receptor gamma	0	1	0	1
Protein kinase C gamma type	0	1	0	1
Protein kinase C beta type	0	1	0	1
Phospholipase D1	0	1	0	1
Platelet-activating factor acetylhydrolase	0	1	0	1
Phospholipase D1	0	1	0	1
Protein kinase C eta type	0	1	0	1
Emopamil-binding protein-like	0	1	0	1
7-dehydrocholesterol reductase	0	1	1	2
Protein kinase C theta type	0	1	0	1
Chain A, Prostatic Acid Phosphatase	0	1	0	1
estrogen receptor beta isoform 1	0	1	0	1
tyrosine-protein phosphatase non-receptor type 7 isoform 2	0	1	0	1
Dihydroxyacetone phosphate acyltransferase	0	0	0	1
Tetracycline resistance protein, class B	0	0	0	1
Multidrug transporter MdfA	0	1	0	1
Neutrophil collagenase	0	1	0	1
Luciferin 4-monooxygenase	0	0	1	1
Ras guanyl-releasing protein 3	0	0	1	1
Cereblon isoform 4	0	2	0	2
DNA-binding protein Ikaros	0	0	0	1
DNA damage-binding protein 1	0	1	1	2
Protein cereblon	0	2	1	4
Chain A, Pyridoxal kinase	0	1	0	1
Chain A, Pyridoxal Kinase	0	1	0	1
Phosphodiesterase	0	2	0	2
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	1	0	1
Thyroid hormone receptor beta	0	1	0	1
Adenosine receptor A1	0	2	0	2
Adenosine receptor A1	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	1	0	1
Thymidine kinase	0	1	0	2
Thymidine kinase	0	1	0	2
Thymidine phosphorylase	0	0	0	1
Thymidine phosphorylase	0	0	0	1
Thymidylate kinase	0	1	0	1
Thymidine kinase, cytosolic	0	0	0	3
Thymidine kinase	0	0	0	1
Thymidylate kinase	0	2	0	2
Thymidine kinase	0	2	0	4
Thymidine kinase	0	1	0	3
Thymidine kinase	0	0	0	1
Chain X, Thyroid hormone receptor beta-1	0	0	1	1
Chain X, Thyroid hormone receptor beta-1	0	0	1	1
Proliferating cell nuclear antigen	0	1	0	1
Malate dehydrogenase, mitochondrial	0	1	0	1
Monocarboxylate transporter 8	0	0	0	1
Solute carrier organic anion transporter family member 1C1	0	0	0	1
P2Y purinoceptor 13	0	1	0	1
Chain A, Tyrosine-protein kinase	0	1	0	1
Chain A, Tyrosine-protein kinase	0	1	0	1
Chain A, Tyrosine-protein kinase JAK2	0	1	0	1
Serine/threonine-protein kinase Sgk1	0	1	0	1
Myosin light chain kinase, smooth muscle	0	0	1	1
Tubulin alpha-1A chain	0	0	1	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	0	1	0	1
Tyrosine-protein kinase JAK3	0	1	0	1
Tyrosine-protein kinase JAK2	0	1	0	1
Tyrosine-protein kinase JAK3	0	1	0	1
Long-chain-fatty-acid--CoA ligase 5	0	0	1	1
Catechol O-methyltransferase	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Genome polyprotein	0	1	1	2
UDP-glucuronosyltransferase 2B15	0	0	0	1
Krueppel-like factor 10	0	1	0	1
Chain A, Carbonic anhydrase 1	0	1	0	1
Carbonic anhydrase 2	0	1	0	1
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with trehalose	0	1	0	1
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with cellobiose	0	1	0	1
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with maltose	0	1	0	1
Trehalose-phosphatase	0	1	0	1
Chain A, Nuclear Receptor ROR-beta	0	1	0	1
Nuclear receptor ROR-alpha	0	1	0	1
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	2	1	3
Nuclear receptor ROR-beta	0	1	0	1
procathepsin L isoform 1 preproprotein	0	1	0	1
Chain A, CARBONIC ANHYDRASE II	0	1	0	1
Chain A, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain K, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain B, tryptophanyl-tRNA synthetase	0	0	1	1
Chain C, Tryptophanyl-tRNA synthetase II	0	0	1	1
Tryprostatin B synthase	0	0	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	0	1	1
Chain A, CHORISMATE MUTASE	0	1	0	1
Chain A, TYROSYL-tRNA SYNTHETASE	0	0	1	1
Tubulin--tyrosine ligase	0	1	0	1
Taste receptor type 2 member 14	0	0	0	1
Solute carrier family 2, facilitated glucose transporter member 9	0	1	1	2
Chain A, Arginase 1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member B7	0	1	0	1
NAD-dependent protein deacylase sirtuin-5, mitochondrial	0	1	0	1
Guanylate cyclase soluble subunit alpha-1	0	0	0	1
2-5A-dependent ribonuclease	0	1	0	1
Proprotein convertase subtilisin/kexin type 7	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	2	0	2
Ectonucleoside triphosphate diphosphohydrolase 1	0	0	0	1
DNA polymerase beta	0	1	0	1
Sphingosine-1-phosphate lyase 1	0	1	0	1
Amine oxidase [flavin-containing]	0	1	0	1
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Synonyms(1)

Research Excerpts

Overview

Context

Treatment

Research

Studies (7,450)

Protein Targets (2,842)

Smoking Cessation

Synonyms(1)

Research Excerpts

Overview

Context

Treatment

Research

Studies (7,450)

Drugs Studied (626)

Protein Targets (2,842)